2026/07/01 更新

写真a

オノ キショウ
小野 喜章
Ono Kisho
所属
医歯薬学域 助教
職名
助教
プロフィール
  • 歯科医師
  • (公社) 日本口腔外科学会認定「口腔外科認定医」
  • (公社) 日本口腔外科学会認定「口腔外科専門医」
  • (一社) 日本がん治療認定医機構「がん治療認定医(歯科口腔外科)」
  • 国際口腔顎顔面外科専門医(Fellow of the International Board for the Certification of Specialists in Oral and Maxillofacial Surgery)
  • (研修歯科医に対する) 歯科医師臨床研修指導歯科医
外部リンク

学位

  • 博士(歯学) ( 2019年3月   岡山大学 )

研究キーワード

  • 口腔外科

  • エクソソーム

  • 薬剤耐性

  • 細胞外小胞

  • 頭頸部癌

  • 口腔癌

学歴

  • 岡山大学   Graduate School of Medicine , Dentistry and Pharmaceutical Sciences  

    2015年4月 - 2019年3月

      詳細を見る

    国名: 日本国

    researchmap

  • 岡山大学   Dental School   School of Dentistry

    2008年4月 - 2014年3月

      詳細を見る

    国名: 日本国

    researchmap

  • 岡山朝日高校    

    2004年4月 - 2007年3月

      詳細を見る

経歴

  • 岡山大学   口腔顎顔面外科学分野   助教

    2026年4月 - 現在

      詳細を見る

  • University of California, San Francisco   Postdoctoral Scholar

    2024年8月 - 2026年3月

      詳細を見る

  • Columbia University Irving Medical Center   Postdoctoral Research Scientist

    2024年2月 - 2024年7月

      詳細を見る

  • 岡山大学病院   口腔外科 口腔顎顔面外科部門   医員

    2022年10月 - 2024年2月

      詳細を見る

  • 岡山大学病院   高度救命救急センター   医員

    2022年4月 - 2022年9月

      詳細を見る

  • 岡山大学病院   口腔外科(病態系)   医員

    2019年4月 - 2022年3月

      詳細を見る

▼全件表示

所属学協会

  • 日本頭頸部癌学会

    2021年 - 現在

      詳細を見る

  • 日本顎変形症学会

    2021年

      詳細を見る

  • 歯科基礎医学会

    2018年

      詳細を見る

  • 日本癌学会

    2017年

      詳細を見る

  • 日本口腔腫瘍学会

    2016年 - 現在

      詳細を見る

  • 日本口腔外科学会

    2015年4月 - 現在

      詳細を見る

  • 日本小児口腔外科学会

      詳細を見る

  • 日本口腔科学会

      詳細を見る

▼全件表示

 

論文

  • Three-dimensional virtual planning reduces operative time in orthognathic surgery: a procedure-specific retrospective study incorporating additive manufacturing. 国際誌

    Yuki Kunisada, Norie Yoshioka, Akiyoshi Nishiyama, Masanori Masui, Koichi Kadoya, Hiroaki Takakura, Kyoichi Obata, Kisho Ono, Koki Umemori, Soichiro Ibaragi

    Oral and maxillofacial surgery   30 ( 1 )   2026年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PURPOSE: Three-dimensional virtual surgical planning (3D-VSP) is increasingly used in orthognathic surgery; however, procedure-specific evidence regarding its real-world impact on operative efficiency and intraoperative blood loss remains limited. This study evaluated the association between 3D-VSP implementation and operative time, and intraoperative blood loss across different orthognathic procedures. METHODS: This retrospective cohort study included consecutive patients who underwent orthognathic surgery at a single academic institution before (2019-2020) and after (2023-2024) the full implementation of 3D-VSP integrated with in-house additive manufacturing (n = 344). Procedure-specific multivariable linear regression analyses were performed, adjusting for age, sex, and surgeon experience. RESULTS: After 3D-VSP implementation, operative time was reduced by approximately 36 min in sagittal split ramus osteotomy (SSRO), 50 min in Le Fort I (LF1) combined with SSRO, and 42 min in segmental LF1 combined with SSRO, representing a 15-20% reduction in total operative time. No meaningful reduction was observed in intraoral vertical ramus osteotomy (IVRO)-based procedures. A statistically significant, but modest, reduction in intraoperative blood loss was observed only in SSRO. The time-saving effect was independent of surgeon experience. CONCLUSION: The clinical benefit of 3D-VSP in orthognathic surgery is procedure-dependent and most evident in geometrically complex SSRO-based operations. These findings support the targeted implementation of digital planning and additive manufacturing workflows to improve operative efficiency in routine practice.

    DOI: 10.1007/s10006-026-01579-9

    PubMed

    researchmap

  • Tumor-Associated Macrophages (TAMs) in Cancer: Functional Programs, Metastatic Mechanisms, and Therapeutic Targeting. 国際誌

    Kisho Ono, Fatemeh Momen-Heravi

    Cancers   18 ( 9 )   2026年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Tumor-associated macrophages (TAMs) are among the most abundant immune cell populations in breast cancer and have emerged as central regulators of tumor progression, metastatic dissemination, immune evasion, and therapeutic resistance. While TAMs were historically described using a simplified M1/M2 polarization framework, accumulating evidence indicates that TAMs in breast cancer comprise a continuum of phenotypic and functional states shaped by ontogeny (tissue-resident vs monocyte-derived), spatial localization (including hypoxic, perivascular, and invasive niches), tumor-intrinsic programs, and therapy-induced selective pressures. In breast cancer, mechanistic studies integrating lineage tracing, intravital imaging, single-cell and spatial profiling, and clinical analyses have established that TAMs actively coordinate rate-limiting steps of the metastatic cascade. These include promotion of angiogenesis and vascular permeability, orchestration of tumor cell invasion and TMEM-mediated intravasation, facilitation of metastatic seeding and niche formation, and suppression of anti-tumor immunity. TAMs also critically influence therapeutic response by modulating chemotherapy efficacy and limiting the activity of immune checkpoint blockade. Therapeutic strategies targeting TAMs in breast cancer have evolved from depletion approaches (CSF1/CSF1R blockade) to inhibition of monocyte recruitment (CCL2/CCR2 axis), functional reprogramming (CD40 agonism, PI3Kγ inhibition), and macrophage-directed checkpoint modulation (CD47-SIRPα axis). Early clinical studies demonstrate clear pharmacodynamic activity but highlight the need for context-specific and combination-based approaches. This review focuses on TAM biology in breast cancer progression and metastasis, synthesizing key mechanistic and translational evidence and proposing a framework in which spatially and functionally defined macrophage states act as rate-limiting regulators of dissemination and therapy response. We further outline principles for rational TAM-targeting strategies that integrate tumor stage, metastatic niche, and treatment context.

    DOI: 10.3390/cancers18091410

    PubMed

    researchmap

  • Bisphosphonate Suppresses the Epithelial–Mesenchymal Transition of Post‐Tooth Extraction Oral Epithelial Cells via Direct and Indirect Pathways

    Hiroshi Hijioka, Tatsuo Okui, Kazuaki Hasegawa, Kisho Ono, Takahiro Kanno, Kouta Yamashiro, Yusaku Noma, Ryota Takaoka, Keitaro Nishi, Toshiyuki Yoneda

    Oral Science International   23 ( 1 )   2025年12月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    ABSTRACT

    Purpose

    Bisphosphonate‐related osteonecrosis of the jaw is thought to be caused by inhibition of osteoclasts, but according to recent research, it has become known that bisphosphonates affect not only osteoclasts but also immune cells and other cells. However, the direct effects of bisphosphonates on the immune system of the mucous membrane covering the bone and oral tissue are not clear.

    Methods

    Using oral mucosal cell lines, we observed the effects of TGF‐β released from bone due to osteoclast‐mediated bone resorption during tooth extraction on oral mucosal cells in vivo and in vitro. These growth factors promote epithelial–mesenchymal transition (EMT) in oral mucosal cells and induce healing of the extraction site.

    Results

    TGF‐β is released from bone due to osteoclast‐mediated bone resorption, but bisphosphonates inhibit osteoclast activity, thereby potentially indirectly inhibiting EMT by blocking the activity of the Smad pathway, a downstream target of TGF‐β signaling. Additionally, bisphosphonates increase the expression of the autophagy marker Beclin, suggesting the influence of autophagy on bone metabolism.

    Conclusion

    In this study, administering bisphosphonate agents during tooth extraction, particularly during osteoporosis treatment, may prevent the onset of BRONJ by temporarily increasing local TGF‐β levels.

    DOI: 10.1002/osi2.70025

    researchmap

  • Peripheral calcifying odontogenic cyst: A case report and literature review

    Izumi Hara, Kyoichi Obata, Nana Yoshitani, Kisho Ono, Hotaka Kawai, Yuki Kunisada, Mayumi Yao, Takayoshi Miyake, Soichiro Ibaragi

    Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology   37 ( 6 )   1314 - 1320   2025年11月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.ajoms.2025.06.004

    researchmap

  • ATPase copper transporting beta contributes to cisplatin resistance as a regulatory factor of extracellular vesicles in head and neck squamous cell carcinoma 査読

    Tatsuo Ogawa, Kisho Ono, Shoji Ryumon, Hotaka Kawai, Kohei Sato, Koki Umemori, Kunihiro Yoshida, Kyoichi Obata, Yuki Kunisada, Tatsuo Okui, Kuniaki Okamoto, Hitoshi Nagatsuka, Fatemeh Momen-Heravi, Soichiro Ibaragi

    Cancer Gene Therapy   2025年10月

     詳細を見る

    担当区分:責任著者   掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    Abstract

    Cisplatin (CDDP) resistance remains a major clinical challenge in the treatment of head and neck squamous cell carcinoma (HNSC). Our group identified ATPase copper transporting beta (ATP7B) as a mediator of CDDP resistance through its role in drug efflux and small extracellular vesicle (sEV) secretion. Herein, we uncovered a novel mechanism by which ATP7B regulates sEV dynamics and the intercellular transmission of CDDP resistance. Using transcriptomic analyses of HNSC datasets, we demonstrate that ATP7B expression correlates with endocytosis- and epithelial-mesenchymal transition (EMT)-related gene sets and with elevated levels of EV-associated proteins. CDDP-resistant HNSC cells exhibited upregulated ATP7B, Rab5/Rab7, and preferentially secreted HSP90- and EpCAM-rich sEVs. These sEVs were leading to increased ATP7B expression and reduced CDDP sensitivity in recipient cells. A pharmacological inhibition of sEV biogenesis with GW4869 suppressed ATP7B and Atox1 expressions, inhibited late endosome maturation, and significantly enhanced CDDP-induced apoptosis in HNSC cells. In vivo, GW4869 reduced the sEV protein content and ATP7B expression in xenograft tumors. These findings establish that ATP7B is a critical modulator of sEV cargo and resistance propagation. Our results highlight a previously unrecognized ATP7B–sEV axis driving chemoresistance and identify sEV inhibition as a promising strategy to overcome therapeutic failure in HNSC.

    DOI: 10.1038/s41417-025-00975-9

    researchmap

    その他リンク: https://www.nature.com/articles/s41417-025-00975-9

  • What Is the Appropriate Sample Size in Human Cadaveric Studies? A Quantitative Review of 770 Articles. 国際誌

    Joe Iwanaga, Kyoichi Obata, Tomotaka Kato, Rarinthorn Samrid, Emma R Lesser, Juan J Cardona, Keishiro Kikuchi, Chung Yoh Kim, Kisho Ono, Anthony D' Antoni, Noritaka Komune, Yoko Tabira, Mi-Sun Hur, Norio Kitagawa, Hee-Jin Kim, Marios Loukas, Koichi Watanabe, R Shane Tubbs

    Clinical anatomy (New York, N.Y.)   2025年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Determining an appropriate sample size in human cadaveric studies remains a long-standing and unresolved challenge. Unlike other basic science fields, anatomical research is constrained by factors such as limited human donor availability, cultural considerations, and ethical restrictions. Despite these limitations, researchers are often asked to justify sample sizes, yet no standardized guidelines currently exist. To quantitatively assess sample sizes in recent human cadaveric studies and propose evidence-based recommendations for future research, a PubMed search was conducted on February 26, 2024, using the term human cadaveric study. The articles published in 2023 and 2024 were screened, yielding 770 eligible studies. Data extracted included the total sample size, number of classified groups, and journal impact factor (IF). Descriptive statistics, linear regression, and correlation analyses were performed. Continuous variables were summarized using medians and interquartile ranges (IQR). The median sample size was 11.5 (IQR: 7-20), and 47.9% of studies used 10 or fewer specimens. The median number of classified groups was 3 (IQR: 2-4). Linear regression showed that studies dividing specimens into 2-6 groups often failed to meet the recommended sample size per group based on regression modeling. No significant correlation was found between sample size and journal IF (r = -0.062, p = 0.115). Most cadaveric studies rely on small sample sizes due to inherent constraints, yet many still attempt a subgroup analysis without sufficient statistical power. Although flexibility is essential in anatomical research, we recommend a minimum total sample size of 10 for basic studies and at least five samples per group for those involving classification. Cadaveric sample size alone does not predict journal impact, highlighting the importance of methodological rigor over quantity.

    DOI: 10.1002/ca.70007

    PubMed

    researchmap

  • Tongue Schwannoma at the Median Inferior Surface in the Elderly: A Case Report. 国際誌

    Kiho Fukushima, Kisho Ono, Kyoichi Obata, Izumi Yamamoto, Yuki Kunisada, Hirokazu Yutori, Soichiro Ibaragi

    Clinical case reports   13 ( 7 )   e70506   2025年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We report the extremely rare case of an atypical schwannoma that occurred at the median inferior surface of the tongue in an elderly patient. We performed an excisional biopsy to achieve a definitive diagnosis. Based on the histopathological findings, we diagnosed a schwannoma (mixed type, Antoni A/B).

    DOI: 10.1002/ccr3.70506

    PubMed

    researchmap

  • A case of chronic sclerosing sublingual sialadenitis caused by a sublingual gland herniation through a hiatus of the mylohyoid muscle

    Koki UMEMORI, Kyoichi OBATA, Kisho ONO, Kunihiro YOSHIDA, Hirokazu YUTORI, Soichiro IBARAGI

    Japanese Journal of Oral and Maxillofacial Surgery   70 ( 11 )   476 - 481   2024年11月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Japanese Society of Oral and Maxillofacial Surgeons  

    DOI: 10.5794/jjoms.70.476

    researchmap

  • 舌下腺ヘルニアにより生じたと考えられた慢性硬化性舌下腺炎の1例 査読

    梅森 洸樹, 小畑 協一, 小野 喜章, 吉田 国弘, 柚鳥 宏和, 伊原木 聰一郎

    日本口腔外科学会雑誌   70 ( 11 )   476 - 481   2024年11月

     詳細を見る

  • 口腔内細菌に起因したと考えられる腰部筋肉内膿瘍の1例

    梅森 洸樹, 小畑 協一, 矢尾 真弓, 竜門 省二, 小川 辰雄, 吉田 国弘, 金本 栄華, 小野 喜章, 國定 勇希, 伊原木 聰一郎

    日本口腔科学会雑誌   73 ( 2 )   198 - 199   2024年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本口腔科学会  

    researchmap

  • Does the anatomy around the pterygomaxillary suture contribute to the risk of bad fractures in Le Fort I osteotomy? 国際誌

    Kyoichi Obata, Hideka Kanemoto, Koki Umemori, Kisho Ono, Norie Yoshioka, Akiyoshi Nishiyama, Joe Iwanaga, Soichiro Ibaragi

    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery   2024年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Le Fort I (LF1) osteotomy, a common orthognathic procedure for the maxilla aimed at achieving maxillary mobility by separating the pterygomaxillary suture, poses a risk of bad fracture that may lead to complications and inadequate mobility. Our study analyzed two- and three-dimensional computed tomography images to identify the anatomical factors associated with bad fractures due to an LF1 osteotomy. Point 'a' is where the lateral pterygomaxillary suture on the axial image aligns with the zygomatic alveolar line near the line used for an LF1 osteotomy, with the base line connecting the bilateral 'a' points.Two risk factors were identified on the pterygoid side: (i) when the distance from point 'a' to the intersection of the base line and the medial pterygoid plate was <6.0 mm; and (ii) when the distance from the piriform aperture margin to the base line was <44.78 mm. Six risk factors were identified on the maxillary side, including the distance between the most anterior and most lateral points of the internal surface of the maxillary sinus being <31.9 mm. Our analyses revealed that fractures that occur during pterygomaxillary suture separation in an LF1 osteotomy are influenced by anatomical factors of the maxilla and pterygoid process, which form the pterygomaxillary suture.

    DOI: 10.1016/j.jcms.2024.02.018

    PubMed

    researchmap

  • Lingual nerve revisited-A comprehensive review Part II: Surgery and radiology. 国際誌

    Kisho Ono, Takashi Nishioka, Kyoichi Obata, Yohei Takeshita, Chista Irani, Yuki Kunisada, Norie Yoshioka, Soichiro Ibaragi, R Shane Tubbs, Joe Iwanaga

    Clinical anatomy (New York, N.Y.)   2024年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The lingual nerve (LN) is a branch of the mandibular division of the fifth cranial nerve, the trigeminal nerve, arising in the infratemporal fossa. It provides sensory fibers to the mucous membranes of the floor of the mouth, the lingual gingiva, and the anterior two-thirds of the tongue. Although the LN should rarely be encountered during routine and basic oral surgical procedures in daily dental practice, its anatomical location occasionally poses the risk of iatrogenic injury. The purpose of this section is to consider this potential LN injury risk and to educate readers about the anatomy of this nerve and how to treat it.

    DOI: 10.1002/ca.24211

    PubMed

    researchmap

  • BIOLOGY TOPICS セツキシマブ抵抗性口腔癌への基礎研究戦略

    小野 喜章, 河合 穂高, 長塚 仁, 伊原木 聰一郎

    BIO Clinica   39 ( 8 )   670 - 675   2024年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)北隆館  

    researchmap

  • BIOLOGY TOPICS セツキシマブ抵抗性口腔癌への基礎研究戦略

    小野 喜章, 河合 穂高, 長塚 仁, 伊原木 聰一郎

    BIO Clinica   39 ( 8 )   670 - 675   2024年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)北隆館  

    researchmap

  • Double-faced CX3CL1 enhances lymphangiogenesis-dependent metastasis in an aggressive subclone of oral squamous cell carcinoma. 国際誌

    Htoo Shwe Eain, Hotaka Kawai, Masaaki Nakayama, May Wathone Oo, Toshiaki Ohara, Yoko Fukuhara, Kiyofumi Takabatake, Quisheng Shan, Yamin Soe, Kisho Ono, Keisuke Nakano, Nobuyoshi Mizukawa, Seiji Iida, Hitoshi Nagatsuka

    JCI insight   9 ( 10 )   2024年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Because cancer cells have a genetically unstable nature, they give rise to genetically different variant subclones inside a single tumor. Understanding cancer heterogeneity and subclone characteristics is crucial for developing more efficacious therapies. Oral squamous cell carcinoma (OSCC) is characterized by high heterogeneity and plasticity. On the other hand, CX3C motif ligand 1 (CX3CL1) is a double-faced chemokine with anti- and pro-tumor functions. Our study reported that CX3CL1 functioned differently in tumors with different cancer phenotypes, both in vivo and in vitro. Mouse OSCC 1 (MOC1) and MOC2 cells responded similarly to CX3CL1 in vitro. However, in vivo, CX3CL1 increased keratinization in indolent MOC1 cancer, while CX3CL1 promoted cervical lymphatic metastasis in aggressive MOC2 cancer. These outcomes were due to double-faced CX3CL1 effects on different immune microenvironments indolent and aggressive cancer created. Furthermore, we established that CX3CL1 promoted cancer metastasis via the lymphatic pathway by stimulating lymphangiogenesis and transendothelial migration of lymph-circulating tumor cells. CX3CL1 enrichment in lymphatic metastasis tissues was observed in aggressive murine and human cell lines. OSCC patient samples with CX3CL1 enrichment exhibited a strong correlation with lower overall survival rates and higher recurrence and distant metastasis rates. In conclusion, CX3CL1 is a pivotal factor that stimulates the metastasis of aggressive cancer subclones within the heterogeneous tumors to metastasize, and our study demonstrates the prognostic value of CX3CL1 enrichment in long-term monitoring in OSCC.

    DOI: 10.1172/jci.insight.174618

    PubMed

    researchmap

  • 細胞外小胞と銅輸送経路調節を介した頭頸部癌におけるシスプラチン耐性機序の解明

    小川 辰雄, 小野 喜章, 小畑 協一, 國定 勇希, 奥井 達雄, 伊原木 聰一郎

    頭頸部癌   50 ( 2 )   159 - 159   2024年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭頸部癌学会  

    researchmap

  • 上顎癒合不全の自然治癒を認めたLe Fort I型骨切り術後Floating Maxillaの2症例

    西山 明慶, 國定 勇希, 竜門 省二, 小野 喜章, 吉岡 徳枝, 伊原木 聰一郎

    日本顎変形症学会雑誌   34 ( 2 )   167 - 167   2024年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本顎変形症学会  

    researchmap

  • 美容整形目的に使用されたヒアルロン酸によりオトガイ部の骨吸収をきたした顎変形症の2例

    吉岡 徳枝, 西山 明慶, 國定 勇希, 坂本 裕美, 小野 喜章, 小畑 協一

    日本口腔診断学会雑誌   37 ( 1 )   85 - 85   2024年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔診断学会  

    researchmap

  • Novel mechanism of cisplatin resistance in head and neck squamous cell carcinoma involving extracellular vesicles and a copper transporter system. 国際誌

    Tatsuo Ogawa, Kisho Ono, Shoji Ryumon, Hotaka Kawai, Tomoya Nakamura, Koki Umemori, Kunihiro Yoshida, Hideka Kanemoto, Kyoichi Obata, Norie Yoshioka, Tatsuo Okui, Kuniaki Okamoto, Hitoshi Nagatsuka, Soichiro Ibaragi

    Head & neck   2024年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Cisplatin (CDDP) plays a central role in chemotherapy for head and neck squamous cell carcinoma (HNSCC), but drug resistance in HNSCC chemotherapy remains a problem, and the mechanism of CDDP resistance is unclear. We investigated CDDP-resistance mechanisms mediated by extracellular vesicles (EVs) and ATPase copper transporting beta (ATP7B) in HNSCC. METHODS: We established CDDP-resistant sublines of HNSCC cells and verified their ATP7B expression. We used an EV secretion inhibitor (GW4869) and ATP7B short hairpin (sh)RNA transfection to examine the correlation between EV secretion and ATP7B expression. RESULTS: The CDDP-resistant HNSCC sublines showed decreased CDDP sensitivity and increased ATP7B expression. GW4869 suppressed ATP7B expression, and ATP7B shRNA transfection suppressed EV secretion. The suppressions of EV secretion and ATP7B expression both enhanced CDDP's cell-killing effect. CONCLUSIONS: EVs were involved in the ATP7B-mediated mechanism underlying CDDP resistance. Further clarification of the EV-induced CDDP-resistance mechanism may lead to novel therapeutic strategies for HNSCC.

    DOI: 10.1002/hed.27620

    PubMed

    researchmap

  • Risk factors for postoperative facial nerve injury in retromandibular-approach surgery: A retrospective study including CT measurements of maxillofacial bone structure 国際誌

    Tomoya Nakamura, Shintaro Sukegawa, Masanori Masui, Kisho Ono, Kazuaki Hasegawa, Ai Fujimura, Tatsuo Okui, Yoshihiko Furuki

    Journal of Cranio-Maxillofacial Surgery   2024年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    The purpose of this retrospective study was to identify risks of postoperative facial nerve injury (FNI) in mandibular condylar fractures. A total of 59 consecutive cases of condyle fracture or plate removal with a retromandibular transparotid approach (RMTA) were divided into FNI and non-FNI groups that were evaluated for associations with age, sex, laterality, fracture type, height, weight, body mass index (BMI), and maxillofacial bone height and width diameters on computed tomography (CT). FNI occurred in 11 of 59 patients (18.64%), all of them female (p = 0.0011). Other statistically significant factors on univariate analysis for FNI included a short height (156.95 ± 8.16 cm vs. 164.29 ± 9.89 cm, p = 0.04), low weight (46.08 ± 8.03 kg vs. 58.94 ± 11.79 kg, p = 0.003), low BMI (18.64 ± 2.63 kg/m2 21.68 ± 3.02 kg/m2, p = 0.007), short condylion-anterior fracture distance (19.34 ± 3.15 mm vs. 22.26 ± 3.96 mm, p = 0.04) and short condylion-posterior fracture distance (20.12 ± 3.98 mm vs. 25.45 ± 5.02 mm, p = 0.009). Our retrospective study suggested that FNI with RMTA surgery occurs particularly in female patients and may occur more frequently in patients who are short, lean or have high condyle fractures.

    DOI: 10.1016/j.jcms.2024.01.015

    PubMed

    researchmap

  • Terrein Exhibits Anti-tumor Activity by Suppressing Angiogenin Expression in Malignant Melanoma Cells. 国際誌

    Taira Hirose, Yuki Kunisada, Koichi Kadoya, Hiroki Mandai, Yumi Sakamoto, Kyoichi Obata, Kisho Ono, Hiroaki Takakura, Kazuhiro Omori, Shogo Takashiba, Seiji Suga, Soichiro Ibaragi

    Cancer genomics & proteomics   21 ( 5 )   464 - 473   2024年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND/AIM: Malignant melanoma is a tumor with a poor prognosis that can metastasize distally at an early stage. Terrein, a metabolite produced by Aspergillus terreus, suppresses the expression of angiogenin, an angiogenic factor. However, the pharmacological effects of natural terrein have not been elucidated, because only a small amount of terrein can be extracted from large fungal cultures. In this study, we investigated the antineoplastic effects of terrein on human malignant melanoma cells and its underlying mechanisms. MATERIALS AND METHODS: Human malignant melanoma cell lines were cultured in the presence of terrein and analyzed. Angiogenin production was evaluated using ELISA. Ribosome biosynthesis was evaluated using silver staining of the nucleolar organizer region. Intracellular signaling pathways were analyzed using western blotting. Malignant melanoma cells were transplanted subcutaneously into the backs of nude mice. The tumors were removed at 5 weeks and analyzed histopathologically. RESULTS: Terrein inhibited angiogenin expression, proliferation, migration, invasion, and ribosome biosynthesis in malignant melanoma cells. Terrein was shown to inhibit tumor growth and angiogenesis in animal models. CONCLUSION: This study demonstrated that terrein has anti-tumor effects against malignant melanoma. Furthermore, chemically synthesized non-natural terrein can be mass-produced and serve as a novel potential anti-tumor drug candidate.

    DOI: 10.21873/cgp.20464

    PubMed

    researchmap

  • A Rare Case of Multiple Myeloma Identified Following the Diagnosis of Amyloidosis of the Tongue. 国際誌

    Hideka Kanemoto, Kyoichi Obata, Koichi Kadoya, Kisho Ono, Hotaka Kawai, Yuki Kunisada, Mayumi Yao, Soichiro Ibaragi

    Case reports in dentistry   2024   8836103 - 8836103   2024年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Amyloidosis is a disease in which amyloid protein is deposited in organs and tissues, resulting in functional impairment. Amyloidosis occurs in 12%-30% of patients with multiple myeloma, but in rare cases, amyloidosis may precede the diagnosis of multiple myeloma. Our patient was a 76-year-old Japanese male on dialysis. Multiple nodules accompanied by ulcers were observed on his tongue. He had no subjective symptoms or clinical findings associated with multiple myeloma. The histopathological findings suggested amyloidosis. We suspected both systemic and localized amyloidosis and performed a comprehensive systemic examination. Since the patient had been on dialysis for only a short period of time (~3 months), dialysis-related amyloidosis was ruled out. After blood and urine tests, a diagnosis of multiple myeloma was made. Chemotherapy treatment was started, but the patient's multiple myeloma could not be suppressed and the tongue amyloidosis worsened, leading to his death 2 years and 2 months after the initial diagnosis.

    DOI: 10.1155/2024/8836103

    PubMed

    researchmap

  • Rab11 suppresses head and neck carcinoma by regulating EGFR and EpCAM exosome secretion. 国際誌

    Kunihiro Yoshida, Kaung Htike, Takanori Eguchi, Hotaka Kawai, Htoo Shwe Eain, Manh Tien Tran, Chiharu Sogawa, Koki Umemori, Tatsuo Ogawa, Hideka Kanemoto, Kisho Ono, Hitoshi Nagatsuka, Akira Sasaki, Soichiro Ibaragi, Kuniaki Okamoto

    Journal of oral biosciences   2023年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVES: Rab11(Rab11a and Rab11b) localizes primarily along recycling endosomes in cells and is involved in various intracellular trafficking processes, including membrane receptor recycling and secretion of exosomes or small extracellular vesicles (EVs). Although Rab11 is closely associated with the progression and metastasis of various cancer types, little is known about Rab11' role in head and neck squamous cell carcinoma (HNSCC). In this study, we investigated the roles of Rab11a and Rab11b in HNSCC. METHODS: The clinical significance of Rab11 expression in HNSCC was investigated using a public database and tissue microarray analysis. Stable cell lines with loss and gain of Rab11a or Rab11b were originally established to investigate their roles in the proliferative, migratory, and invasive capabilities of HNSCC cells. RESULTS: Database analysis revealed a significant association between Rab11b mRNA expression and a favorable patient survival rate in HNSCC. Tissue microarray analysis revealed that Rab11b expression was the highest in normal tissues and gradually decreased across the stages of HNSCC progression. Overexpression of Rab11a or Rab11b resulted in a decrease in epidermal growth factor receptor (EGFR), Epithelial cell adhesion molecule (EpCAM) exosome secretion, and the migratory and invasive potential of HNSCC cells. The knockdown of Rab11a or Rab11b increased EpCAM/CD9 exosome secretion in addition to the migratory and invasive potential of HNSCC cells. CONCLUSIONS: Rab11 suppresses HNSCC by regulating EGFR recycling and EpCAM exosome secretion in HNSCC cells. Our results indicate that Rab11b is a superior prognostic indicator of HNSCC and holds promise for developing novel therapeutic strategies.

    DOI: 10.1016/j.job.2023.11.007

    PubMed

    researchmap

  • 舌下面に発生した神経鞘腫の1例

    福嶋 輝保, 小野 喜章, 山本 和泉, 小畑 協一, 國定 勇希, 柚鳥 宏和, 伊原木 聰一郎

    日本口腔科学会雑誌   72 ( 4 )   255 - 255   2023年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本口腔科学会  

    researchmap

  • 上顎前歯部歯肉に発生した周辺性石灰化歯原性嚢胞の1例

    山本 和泉, 小畑 協一, 矢尾 真弓, 福嶋 輝保, 小野 喜章, 國定 勇希, 伊原木 聰一郎

    日本口腔科学会雑誌   72 ( 4 )   256 - 256   2023年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本口腔科学会  

    researchmap

  • 口腔外科受診を契機に診断・治療に至った舌咽神経痛の1例

    木村 拓紀, 小野 喜章, 福嶋 輝保, 小畑 協一, 國定 勇希, 伊原木 聰一郎

    日本口腔科学会雑誌   72 ( 4 )   254 - 254   2023年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本口腔科学会  

    researchmap

  • 美容整形目的に使用されたヒアルロン酸によりオトガイ部の骨吸収をきたした顎変形症の2例

    吉岡 徳枝, 西山 明慶, 國定 勇希, 坂本 裕美, 小野 喜章, 小畑 協一

    日本口腔内科学会雑誌   29 ( 2 )   87 - 87   2023年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • Mylohyoid Muscle: Current Understanding for Clinical Management Part II: Clinical Anatomy, Radiology, and Surgical/Clinical Relevance. 国際誌

    Kyoichi Obata, Norio Kitagawa, Kisho Ono, Hideka Kanemoto, Keiko Fukino, Yohei Takeshita, Soichiro Ibaragi, R Shane Tubbs, Joe Iwanaga

    The Journal of craniofacial surgery   2023年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The mylohyoid is one of the suprahyoid muscles along with the geniohyoid, digastric, and stylohyoid muscles that lies between the anterior belly of the digastric muscle inferiorly and the geniohyoid superiorly. In Part II, the radiology and clinical/surgical importance of the mylohyoid muscle will be discussed.

    DOI: 10.1097/SCS.0000000000009797

    PubMed

    researchmap

  • Mylohyoid Muscle: Current Understanding for Clinical Management-Part I: Anatomy and Embryology. 国際誌

    Kyoichi Obata, Norio Kitagawa, Kisho Ono, Hideka Kanemoto, Keiko Fukino, Yohei Takeshita, Soichiro Ibaragi, Richard S Tubbs, Joe Iwanaga

    The Journal of craniofacial surgery   2023年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The mylohyoid is one of the suprahyoid muscles, along with the geniohyoid, digastric, and stylohyoid muscles. It lies between the anterior belly of the digastric muscle inferiorly and the geniohyoid superiorly. In Part I, the anatomy and embryology of the mylohyoid muscle will be reviewed in preparation for the clinical discussion in Part II.

    DOI: 10.1097/SCS.0000000000009812

    PubMed

    researchmap

  • Multimodal Prediction of Cervical Lymph Node Metastasis and Recurrence in Oral Squamous Cell Carcinoma. 国際誌

    Hideka Kanemoto, Kyoichi Obata, Koki Umemori, Kazuaki Hasegawa, Sawako Ono, Kisho Ono, Hirokazu Yutori, Soichiro Ibaragi

    Anticancer research   43 ( 11 )   4993 - 5001   2023年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND/AIM: Oral squamous cell carcinoma (OSCC) is the most common malignancy in the head/neck region, and cervical lymph node (CLN) metastasis is a strong poor-prognosis factor. In addition, many patients with OSCC experience recurrence despite multidisciplinary treatment. We sought to identify factors associated with CLN metastasis and recurrence in patients with OSCC. PATIENTS AND METHODS: We evaluated a total of 45 patients and 233 target CLNs. The longest diameter of the target CLN, the shortest diameter of the target CLN (LS), the area of the target CLN, and the relative computed tomography (CT) values of the target CLNs calculated based on the CT values of the internal jugular vein (LCT) were obtained from preoperative CT images, and the maximum standardized uptake values of the primary tumor (pSUV) and target CLN (nSUV) were obtained from preoperative 18F-fluorodeoxyglucose-positron emission tomography/CT images. We performed immunohistochemical staining for cytokeratin 13 (CK13) and 17 (CK17) on neck dissection tissues. RESULTS: A discrimination equation was used that can predict CLN metastasis with a 92.2% discrimination rate using LS, LCT, pSUV, and nSUV. The CLNs were divided into discrimination and non-discrimination groups based on discriminant equations and CK13 and CK17 were used as the objective variables. A significantly higher recurrence rate was observed in the non-discrimination group (CK13: 5-year recurrence rate 28.6% vs. 64.3%, p<0.01; CK17: 5-year recurrence rate 28.0% vs. 76.0%, p<0.01). CONCLUSION: CLN metastases in OSCC can be assessed by combining preoperative imaging. The combined use of CK13 and CK17 expression with imaging findings offers an integrated approach to predict OSCC recurrence.

    DOI: 10.21873/anticanres.16698

    PubMed

    researchmap

  • 口腔癌の細胞外小胞と銅輸送経路に着目したシスプラチン耐性機構の解明と克服のための挑戦的研究

    小野 喜章, 竜門 省二, 小畑 協一, 河合 穂高, 奥井 達雄, 伊原木 聰一郎

    日本口腔科学会雑誌   72 ( 2 )   131 - 131   2023年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本口腔科学会  

    researchmap

  • 顔面軟部組織に発生したランゲルハンス細胞組織球症の1例 査読

    増井正典, 吉岡徳枝, 伊原木聰一郎, 小野喜章, 長塚仁, 佐々木朗

    日本口腔外科学会雑誌   69 ( 6 )   298 - 303   2023年6月

     詳細を見る

    記述言語:日本語  

    researchmap

  • EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma. 国際誌

    Koki Umemori, Kisho Ono, Takanori Eguchi, Hotaka Kawai, Tomoya Nakamura, Tatsuo Ogawa, Kunihiro Yoshida, Hideka Kanemoto, Kohei Sato, Kyoichi Obata, Shoji Ryumon, Hirokazu Yutori, Naoki Katase, Tatsuo Okui, Hitoshi Nagatsuka, Soichiro Ibaragi

    Oral oncology   142   106433 - 106433   2023年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVES: Cetuximab (Cmab) is a molecularly targeted monoclonal antibody drug for head and neck squamous cell carcinoma (HNSC), although cetuximab resistance is a serious challenge. Epithelial cell adhesion molecule (EpCAM) is an established marker for many epithelial tumors, while the soluble EpCAM extracellular domain (EpEX) functions as a ligand for epidermal growth factor receptor (EGFR). We investigated the expression of EpCAM in HNSC, its involvement in Cmab action, and the mechanism by which soluble EpEX activated EGFR and played key roles in Cmab resistance. MATERIALS AND METHODS: We first examined EPCAM expression in HNSCs and its clinical significance by searching gene expression array databases. We then examined the effects of soluble EpEX and Cmab on intracellular signaling and Cmab efficacy in HNSC cell lines (HSC-3 and SAS). RESULTS: EPCAM expression was found to be enhanced in HNSC tumor tissues compared to normal tissues, and the enhancement was correlated with stage progression and prognosis. Soluble EpEX activated the EGFR-ERK signaling pathway and nuclear translocation of EpCAM intracellular domains (EpICDs) in HNSC cells. EpEX resisted the antitumor effect of Cmab in an EGFR expression-dependent manner. CONCLUSION: Soluble EpEX activates EGFR to increase Cmab resistance in HNSC cells. The EpEX-activated Cmab resistance in HNSC is potentially mediated by the EGFR-ERK signaling pathway and the EpCAM cleavage-induced nuclear translocation of EpICD. High expression and cleavage of EpCAM are potential biomarkers for predicting the clinical efficacy and resistance to Cmab.

    DOI: 10.1016/j.oraloncology.2023.106433

    PubMed

    researchmap

  • 上顎のカントを伴う非対称に対して非偏位側をTrauner-Obwegeser法に準じて骨切りした2例

    小野 喜章, 吉岡 徳枝, 小畑 協一, 坂本 裕美, 西山 明慶, 伊原木 聰一郎

    日本顎変形症学会雑誌   33 ( 2 )   181 - 181   2023年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本顎変形症学会  

    researchmap

  • 翼突上顎縫合を正常に分離するために必要な幾何学的因子の統計学的検討

    小畑 協一, 吉岡 徳枝, 坂本 裕美, 小野 喜章, 西山 明慶, 伊原木 聰一郎

    日本顎変形症学会雑誌   33 ( 2 )   168 - 168   2023年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本顎変形症学会  

    researchmap

  • Le Fort I型骨切り術と片側SSRO,分割オトガイ形成術で治療した第一第二鰓弓症候群による顔面非対称の1例

    西山 明慶, 小畑 協一, 國定 勇希, 竜門 省二, 小野 喜章, 吉岡 徳枝, 伊原木 聰一郎

    日本顎変形症学会雑誌   33 ( 2 )   180 - 180   2023年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本顎変形症学会  

    researchmap

  • Lactate secreted via MCT4 from bone‑colonizing breast cancer excites sensory neurons via GPR81. 国際誌

    Tatsuo Okui, Masahiro Hiasa, Kazuaki Hasegawa, Tomoya Nakamura, Kisho Ono, Soichiro Ibaragi, Takahiro Kanno, Akira Sasaki, Toshiyuki Yoneda

    International journal of oncology   62 ( 3 )   2023年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Breast cancer (BC) bone metastasis causes bone pain (BP), which detrimentally damages the quality of life and outcome of patients with BC. However, the mechanism of BC‑BP is poorly understood, and effective treatments are limited. The present study demonstrated a novel mechanism of BC‑BP using a mouse model of bone pain, in which mouse (EO771) and human (MDA‑MB‑231) BC cells were injected in the bone marrow cavity of tibiae. Western blot analysis using sensory nerves, in vivo assessment of cancer pain and in vitro calcium flux analysis were performed. These mice developed progressive BC‑BP in tibiae in conjunction with an upregulation of phosphorylated pERK1/2 and cAMP‑response element‑binding protein (pCREB), which are molecular indicators of neuron excitation, in the dorsal root ganglia (DRG) of sensory nerves. Importantly, mice injected with BC cells, in which the expression of the lactic acid transporter monocarboxylate transporter 4 (MCT4) was silenced, exhibited decreased BC‑BP with downregulated expression of pERK1/2 and pCREB in the DRG and reduced circulating levels of lactate compared with mice injected with parental BC cells. Further, silencing of the cell‑surface orphan receptor for lactate, G protein‑coupled receptor 81 (GPR81), in the F11 sensory neuron cells decreased lactate‑promoted upregulation of pERK1/2 and Ca2+ influx, suggesting that the sensory neuron excitation was inhibited. These results suggested that lactate released from BC cells via MCT4 induced BC‑BP through the activation of GPR81 of sensory neurons. In conclusion, the activation of GPR81 of sensory neurons by lactate released via MCT4 from BC was demonstrated to contribute to the induction of BC‑BP, and disruption of the interactions among lactate, MCT4 and GPR81 may be a novel approach to control BC‑BP.

    DOI: 10.3892/ijo.2023.5487

    PubMed

    researchmap

  • 口腔扁平上皮癌におけるEpCAM誘導性セツキシマブ耐性獲得機構の解明

    梅森 洸樹, 小野 喜章, 金本 栄華, 小畑 協一, 吉岡 徳枝, 伊原木 聰一郎

    日本口腔診断学会雑誌   36 ( 1 )   68 - 69   2023年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔診断学会  

    researchmap

  • シスプラチン耐性機構の解明に向けた口腔癌の細胞外小胞と銅輸送経路の検討

    小野 喜章, 小川 辰雄, 竜門 省二, 吉田 国弘, 金本 栄華, 梅森 洸樹, 坂本 裕美, 増井 正典, 小畑 協一, 奥井 達雄, 伊原木 聰一郎

    口腔組織培養学会誌   32 ( 1 )   27 - 29   2023年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本口腔組織培養学会  

    researchmap

  • 細胞外小胞と銅輸送経路に着目した口腔癌のシスプラチン耐性機構の解明

    小野 喜章, 竜門 省二, 金本 栄華, 梅森 洸樹, 坂本 裕美, 小畑 協一, 吉岡 徳枝, 伊原木 聰一郎, 佐々木 朗

    日本口腔診断学会雑誌   36 ( 1 )   59 - 60   2023年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔診断学会  

    researchmap

  • EGFR活性化経路としてのEpCAMに着目した口腔扁平上皮癌のセツキシマブ耐性機構の解明

    梅森 洸樹, 小野 喜章, 小畑 協一, 竜門 省二, 中村 友哉, 金本 栄華, 吉田 国弘, 河合 穂高, 伊原木 聰一郎

    口腔組織培養学会誌   32 ( 1 )   11 - 12   2023年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本口腔組織培養学会  

    researchmap

  • 顎舌骨筋の裂隙に舌下腺が嵌頓したことにより生じた慢性硬化性唾液腺炎の一例

    小畑 協一, 柚鳥 宏和, 金本 栄華, 梅森 洸樹, 坂本 裕美, 小野 喜章, 伊原木 聰一郎

    日本口腔診断学会雑誌   36 ( 1 )   65 - 65   2023年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔診断学会  

    researchmap

  • 口腔扁平上皮癌頸部リンパ節転移を放射線学的,病理組織学的に評価する手法の立案

    金本 栄華, 小畑 協一, 梅森 洸樹, 竜門 省二, 小野 喜章, 伊原木 聰一郎

    日本口腔診断学会雑誌   36 ( 1 )   68 - 68   2023年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔診断学会  

    researchmap

  • Lingual nerve impairment/injury after retrieval of the displaced mandibular third molar into the floor of the mouth. 国際誌

    Joe Iwanaga, Tomotaka Kato, Kisho Ono, R Shane Tubbs, Soichiro Ibaragi

    The British journal of oral & maxillofacial surgery   61 ( 3 )   193 - 197   2023年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Retrieval of the displaced mandibular third molar in the floor of the mouth is challenging as the lingual nerve is always at risk of injury. However, there are no available data to show the incidence of the injury caused by the retrieval. The goal of this review article is to provide the incidence of the iatrogenic lingual nerve impairment/injury caused by the retrieval based on the review of the existing literature. The retrieval cases were collected with the search words below using PubMed, Google Scholar, and CENTRAL Cochrane Library database on October 6, 2021. A total of 38 cases of lingual nerve impairment/injury in 25 studies were eligible and reviewed. Temporary lingual nerve impairment/injury due to retrieval was found in six cases (15.8%) and all recovered between three to six months after retrieval. General anaesthesia and local anaesthesia were used for retrieval in three cases each. The tooth was retrieved using a lingual mucoperiosteal flap in all six cases. The permanent iatrogenic lingual nerve impairment/injury due to retrieval of the displaced mandibular third molar is considered extremely rare as long as the appropriate surgical approach is chosen based on surgeons' clinical experience and anatomical knowledge.

    DOI: 10.1016/j.bjoms.2023.01.002

    PubMed

    researchmap

  • Multiple Targeting of HSP Isoforms to Challenge Isoform Specificity and Compensatory Expression. 国際誌

    Kisho Ono, Takanori Eguchi

    Methods in molecular biology (Clifton, N.J.)   2693   141 - 161   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Heat shock proteins (HSPs) are molecular chaperones that assist in protein folding, trafficking, and metabolism. Intracellular chaperone functions of HSPs had been well-investigated, but extracellular and exosomal HSPs have been recently found. Exosomal HSPs are intercellularly transferred, while extracellular HSPs play cytokine-like roles called chaperokines. We have shown that exosomal HSPs play key roles in intercellular communication between tongue carcinoma and tumor-associated macrophages in the tumor microenvironment. Notably, HSP90 isoforms consist of HSP90alpha, HSP90beta, mitochondrial TRAP1, and GRP94 in the endoplasmic reticulum. Moreover, many pseudogenes of HSP90 can be transcribed into RNA. Besides, the function of HSP90 is defined by their cochaperones, such as CDC37 or AHA1. Therefore, isoform-specific small interfering RNA (siRNA) is necessary for precisely targeting each HSP90 isoform and cochaperone. Nevertheless, we often encountered compensatory expression of HSP90 isoforms in the knockdown studies. Here, we provide dual and triple knockdown methods to target multiple RNA for challenging isoform-specific roles and compensatory expression of intracellular, extracellular, and exosomal HSPs.

    DOI: 10.1007/978-1-0716-3342-7_12

    PubMed

    researchmap

  • Multiplex Immunostaining Method to Distinguish HSP Isoforms in Cancer Tissue Specimens. 国際誌

    Hotaka Kawai, Kisho Ono, Takanori Eguchi

    Methods in molecular biology (Clifton, N.J.)   2693   281 - 291   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Heat shock proteins (HSPs) are often expressed in all nucleated cells, but their expression profiles differ. In particular, HSP90α and HSP90β have high sequence identity and have not been fully examined for their individual and compensatory functions as molecular chaperones, differences in client proteins, and extracellular distributions with exosomes. Immunohistochemical staining is a technique to visualize the presence and localization of target antigens using specific antibodies, of which the multiplex immunostaining method can reveal differences in protein expression in the same tumor tissue and the localization of proteins of interest within tumor tissue or single cells. The common multiplex immunostaining method uses multiple secondary antibodies of different reacting animal species to identify and detect different antigens, thus requiring different animals to be immunized with each primary antibody. Furthermore, the fluorescent-antibody method is the predominant multiplex staining method but has the critical disadvantage that permanent specimens cannot be prepared. Here, we outline a multiplex staining method for HSP90α and HSP90β based on the enzyme-antibody method that allows permanent specimens to be prepared without the restriction of immunized animal species.

    DOI: 10.1007/978-1-0716-3342-7_21

    PubMed

    researchmap

  • Preservation of the nerve to the mylohyoid muscle during submental island flaps: An anatomical feasibility study for facial nerve reanimation procedures. 国際誌

    Kisho Ono, Soichiro Ibaragi, Kyoichi Obata, Tatsuo Okui, Norio Kitagawa, R. Shane Tubbs, Joe Iwanaga

    J Craniofac Surg   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The submental island flap is an axial pattern pedicle flap widely used in head and neck surgery because of its ease and success. Indications of the submental island flap range from reconstruction for the malignant tumor resection to loss of temporal bone and facial skin due to trauma. Whereas, intraoperative facial nerve injury is not uncommon. We verified whether it was possible to localize the nerve to the mylohyoid muscle and reanimate the facial nerve during submental island flap procedures by preserving the mylohyoid muscle using human fresh cadaveric specimens. Six cadaveric heads were dissected and the position of the nerve to the mylohyoid muscle identified to the mylohyoid triangle documented. We identified the nerve to the mylohyoid muscle on all sides within the mylohyoid triangle and were able to separate the nerve from the submental island flap completely. Our results suggest that facial nerve reanimation using the nerve to the mylohyoid muscle can be used while reconstructing with a submental island flap in cases of intraoperative facial nerve injury.

    DOI: 10.1097/SCS.0000000000009589

    PubMed

    researchmap

  • Proteomic Profiling of the Extracellular Vesicle Chaperone in Cancer. 国際誌

    Kisho Ono, Takanori Eguchi

    Methods in molecular biology (Clifton, N.J.)   2693   233 - 249   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Molecular chaperones are widely distributed intracellular proteins that play essential roles in maintaining proteome function by assisting in the folding of client proteins. Molecular chaperones, such as heat shock proteins (HSPs), are found intracellularly and extracellularly. Extracellular vesicles (EVs), such as exosomes, contain HSPs and horizontally transfer the functional chaperones into various recipient cells. Besides, mass spectrometry has enabled a comprehensive analysis of exosomal and EV proteins, which is useful in basic biomedical research to clinical biomarker search. We have performed deep proteome analysis of EVs, including exosomes, from metastatic tongue and prostate cancers and detected >700 protein types, including cytoplasmic, ER, mitochondrial, small, and large HSPs. Here, we provide protocols for isolating exosomes/EVs and deep proteome analysis to detect the EV chaperone.

    DOI: 10.1007/978-1-0716-3342-7_18

    PubMed

    researchmap

  • Large-Scale Databases and Portals on Cancer Genome to Analyze Chaperone Genes Correlated to Patient Prognosis. 国際誌

    Kisho Ono, Takanori Eguchi

    Methods in molecular biology (Clifton, N.J.)   2693   293 - 306   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Molecular chaperones, such as heat shock proteins (HSPs), have attracted attention as molecules involved in malignant events in cancers and are potential therapeutic targets and biomarkers for tumor therapy. Furthermore, mutations in chaperones can significantly impact cancer risk and prognosis. Bioinformatics is a particularly useful method for developing biomarkers as a practical consideration for the immediate clinical application of data. Many large-scale databases and portals on cancer genome are nowadays publicly available, including the International Cancer Genome Consortium (ICGC); The Cancer Genome Atlas (TCGA), renamed as Genomic Data Commons (GDC); Catalogue of Somatic Mutations in Cancer (COSMIC); and Cancer Cell Line Encyclopedia (CCLE). Referring to these databases, advanced web portals are publicized, including cBioPortal, Human Protein Atlas (HPA), Kaplan-Meier (KM) plotter, Gene Expression Profiling Interactive Analysis 2 (GEPIA2), Genomics of Drug Sensitivity in Cancer (GDSC), and Dependency Map (DepMap). Here, we assemble these databases and portals to clarify what is available and useful for current cancer research and provide protocols to utilize the HPA, KM plotter, and GEPIA2 for studies on chaperone genes in cancer patients. Utilizing these portals will reveal the correlation between tumor subtype-specific high expression of chaperone genes and patient prognosis. Our protocols are useful to increase systematic awareness of chaperones and find new biomarkers for diagnosis and prognosis and new targets for anticancer drugs.

    DOI: 10.1007/978-1-0716-3342-7_22

    PubMed

    researchmap

  • 口腔扁平上皮癌におけるEpCAM誘導性セツキシマブ耐性獲得機構の解明

    梅森 洸樹, 小野 喜章, 金本 栄華, 小畑 協一, 吉岡 徳枝, 伊原木 聰一郎

    日本口腔内科学会雑誌   28 ( 2 )   92 - 93   2022年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • 口腔扁平上皮癌におけるEpCAM誘導性セツキシマブ耐性獲得機構の解明

    梅森 洸樹, 小野 喜章, 金本 栄華, 小畑 協一, 吉岡 徳枝, 伊原木 聰一郎

    日本口腔内科学会雑誌   28 ( 2 )   92 - 93   2022年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • 口腔扁平上皮癌頸部リンパ節転移を放射線学的,病理組織学的に評価する手法の立案

    金本 栄華, 小畑 協一, 梅森 洸樹, 竜門 省二, 小野 喜章, 伊原木 聰一郎

    日本口腔内科学会雑誌   28 ( 2 )   92 - 92   2022年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • 細胞外小胞と銅輸送経路に着目した口腔癌のシスプラチン耐性機構の解明

    小野 喜章, 竜門 省二, 金本 栄華, 梅森 洸樹, 坂本 裕美, 小畑 協一, 吉岡 徳枝, 伊原木 聰一郎, 佐々木 朗

    日本口腔内科学会雑誌   28 ( 2 )   83 - 84   2022年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • 顎舌骨筋の裂隙に舌下腺が嵌頓したことにより生じた慢性硬化性唾液腺炎の一例

    小畑 協一, 柚鳥 宏和, 金本 栄華, 梅森 洸樹, 坂本 裕美, 小野 喜章, 伊原木 聰一郎

    日本口腔内科学会雑誌   28 ( 2 )   89 - 89   2022年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • 細胞外小胞と銅輸送経路に着目した口腔癌のシスプラチン耐性機構の解明

    小野 喜章, 竜門 省二, 金本 栄華, 梅森 洸樹, 坂本 裕美, 小畑 協一, 吉岡 徳枝, 伊原木 聰一郎, 佐々木 朗

    日本口腔内科学会雑誌   28 ( 2 )   83 - 84   2022年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • 顎舌骨筋の裂隙に舌下腺が嵌頓したことにより生じた慢性硬化性唾液腺炎の一例

    小畑 協一, 柚鳥 宏和, 金本 栄華, 梅森 洸樹, 坂本 裕美, 小野 喜章, 伊原木 聰一郎

    日本口腔内科学会雑誌   28 ( 2 )   89 - 89   2022年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • 口腔扁平上皮癌頸部リンパ節転移を放射線学的,病理組織学的に評価する手法の立案

    金本 栄華, 小畑 協一, 梅森 洸樹, 竜門 省二, 小野 喜章, 伊原木 聰一郎

    日本口腔内科学会雑誌   28 ( 2 )   92 - 92   2022年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • Lip pleomorphic adenomas: case series and literature review 国際誌

    Koki Umemori, Kisho Ono, Hideka Kanemoto, Kyoichi Obata, Hotaka Kawai, Tomoya Nakamura, Keisuke Nakano, Soichiro Ibaragi, Hitoshi Nagatsuka, Akira Sasaki

    Gland Surgery   11 ( 10 )   1730 - 1740   2022年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AME Publishing Company  

    Background: Pleomorphic adenoma (PA) is the most frequent benign salivary gland tumor, but a lip PA is rare. Although this tumor may be definitively diagnosed by imaging or a tissue biopsy if it is reasonably large, PAs on the lip are relatively small, and they present findings that are similar to those of other lip lesions, which can make a preoperative diagnosis difficult. Methods: We analyzed all PAs in the oral region and lesions on the lips treated in our department over the past 20 years, and we discuss them together with the relevant literature. Results: We found that 11.8% (n=6) of the PAs occurred on a lip (upper lip: 9.8%, lower lip: 2.0%), and ~1% of all mass lesions of the lips were PAs. The average size of the lip PAs was 1.5±0.7 cm (range, 0.7-2.2 cm). For preoperative diagnostic assistance, ultrasonography (US) (n=4), magnetic resonance (MR) (n=3), or no imaging (n=2) was used. An excisional biopsy was performed in all cases, and to date, no recurrence or malignant transformation has been observed. Conclusions: Lip PA is relatively rare. Because almost all of these lesions are small, a preoperative diagnosis is more difficult compared to palatal lesions. This tumor is also prone to long-term neglect and has the potential for recurrence and malignant transformation. It is thus necessary to perform an excision that includes the capsule and surrounding tissues, and careful postoperative follow-up should be continued.

    DOI: 10.21037/gs-22-308

    PubMed

    researchmap

  • Relationships between squamous cell carcinoma antigen and cytokeratin 19 fragment values and renal function in oral cancer patients. 国際誌

    K Obata, H Yutori, K Yoshida, Y Sakamoto, K Ono, S Ibaragi

    International journal of oral and maxillofacial surgery   2022年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Squamous cell carcinoma antigen (SCC-Ag) and cytokeratin 19 fragment (CYFRA) are used to screen and monitor oral cancer patients. However, recent studies have reported that tumour markers become elevated as renal function decreases, regardless of tumour progression. A retrospective study was performed of 423 oral cancer patients who underwent blood testing for these tumour markers and other blood analytes during a 10-year period. The values of SCC-Ag and CYFRA increased significantly with decreasing renal function (P < 0.01), and the values were abnormal at a median 2.6 ng/ml for SCC-Ag and 4.7 ng/ml for CYFRA in the group with estimated glomerular filtration rate (eGFR) values of< 30 ml/min/1.73 m2. The factors that were related to the variation in tumour markers were albumin and creatinine. The cut-off values of eGFR were 59.7 ml/min/1.73 m2 for SCC-Ag and 63.6 ml/min/1.73 m2 for CYFRA, and the cut-off age when the tumour markers might rise due to the effect of renal function were 72 years for SCC-Ag and 73 years for CYFRA. In conclusion, decreased renal function should be taken into account when evaluating tumour markers in oral cancer. In addition, tumour markers are likely to be overestimated in patients over the age of 72-73 years.

    DOI: 10.1016/j.ijom.2022.08.019

    PubMed

    researchmap

  • Craniomaxillofacial Fibrous Dysplasia Improved Cosmetic and Occlusal Problem by Comprehensive Treatment: A Case Report and Review of Current Treatments. 国際誌

    Kisho Ono, Norie Yoshioka, Yuki Kunisada, Tomoya Nakamura, Yuko Nakamura, Kyoichi Obata, Soichiro Ibaragi, Shogo Minagi, Akira Sasaki

    Diagnostics (Basel, Switzerland)   12 ( 9 )   2022年9月

     詳細を見る

    記述言語:英語  

    Fibrous dysplasia (FD) is a fibrous lesion of immature bone, with an incidence of 10-20% in the head and neck region. Most cases are monostotic, but when a lesion occurs on the maxillofacial region and spreads to the surrounding bone, it is classified as polyostotic, despite its localized occurrence. In some cases, surgical intervention is required to improve the cosmetic or functional disturbance of a FD in the maxillofacial region, but it is necessary to confirm symmetry of the maxillofacial region in real time, and a surgical support system is required to compensate. Furthermore, prosthetic intervention is considered when postoperative acquired defects occur or further cosmetic or occlusal function improvement is needed. A comprehensive approach by an oral surgeon and a maxillofacial prosthodontist is necessary for the successful treatment and rehabilitation of such patients. In this article, we describe the case of a craniomaxillofacial FD patient with facial asymmetry and denture incompatibility with improved quality of life measures by integrating surgical treatment using a navigation system and postoperative prosthetic rehabilitation. We also discuss recent diagnostic methods and treatment strategies for craniomaxillofacial FD in the literature.

    DOI: 10.3390/diagnostics12092146

    PubMed

    researchmap

  • 高転移性癌細胞由来の細胞外小胞に搭載されたMMP3によるCtgf/Ccn2発現調節機能と癌転移促進(Extracellular vesicles enriched with moonlighting metalloproteinase are highly transmissive, Pro-tumorigenic, and trans-activates cellular communication network factor(CCN2/CTGF): CRISPR against cancer)

    奥舎 有加, 江口 傑徳, Tran Manh T., 十川 千春, 吉田 賀弥, 板垣 まみ, Taha Eman A., 小野 喜章, 青山 絵理子, 岡村 裕彦, 小崎 健一, Calderwood Stuart K., 滝川 正春, 岡元 邦彰

    Journal of Oral Biosciences Supplement   2022   35 - 35   2022年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)歯科基礎医学会  

    researchmap

  • 口腔癌間質由来のCCL2はCCR2陽性骨髄由来免疫抑制細胞の腫瘍間質への動員に関与する

    河合 穂高, メイ・ワトウ, 高畠 清文, 冨田 秀太, 小野 喜章, 江口 傑徳, 大原 利章, 中野 敬介, 長塚 仁

    日本がん免疫学会総会プログラム・抄録集   26回   91 - 91   2022年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本がん免疫学会  

    researchmap

  • 口腔癌間質由来のCCL2はCCR2陽性骨髄由来免疫抑制細胞の腫瘍間質への動員に関与する

    河合 穂高, メイ・ワトウ, 高畠 清文, 冨田 秀太, 小野 喜章, 江口 傑徳, 大原 利章, 中野 敬介, 長塚 仁

    日本がん免疫学会総会プログラム・抄録集   26回   91 - 91   2022年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本がん免疫学会  

    researchmap

  • 頭頸部扁平上皮癌におけるEpCAM誘導性セツキシマブ耐性獲得機構の解明

    小野 喜章, 小畑 協一, 増井 正典, 吉岡 徳枝, 伊原木 聰一郎, 佐々木 朗

    頭頸部癌   48 ( 2 )   211 - 211   2022年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭頸部癌学会  

    researchmap

  • 侵襲性歯周炎の血液診断マーカー候補となる細胞外小胞由来マイクロRNAとその炎症誘導機構の探索

    森 彩乃, 山本 直史, 井手口 英隆, 河村 麻理, 河本 美奈, 伊東 昌洋, 小野 喜章, 中山 真彰, 江口 傑徳, 大野 充昭, 大森 一弘, 高柴 正悟

    日本歯周病学会会誌   64 ( 春季特別 )   114 - 114   2022年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本歯周病学会  

    researchmap

  • 顎矯正手術後に再手術を要した症例の検討

    吉田 国弘, 吉岡 徳枝, 西山 明慶, 竜門 省二, 小野 喜章, 増井 正典, 小畑 協一, 伊原木 聰一郎, 佐々木 朗

    日本顎変形症学会雑誌   32 ( 2 )   201 - 201   2022年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本顎変形症学会  

    researchmap

  • 当科における顎矯正手術症例の臨床統計的観察

    西山 明慶, 吉岡 徳枝, 國定 勇希, 小畑 協一, 増井 正典, 小野 喜章, 竜門 省二, 伊原木 聰一郎, 佐々木 朗

    日本顎変形症学会雑誌   32 ( 2 )   222 - 222   2022年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本顎変形症学会  

    researchmap

  • Le Fort I型骨切り術における翼突上顎縫合部の異常骨折に関する統計学的検討

    小畑 協一, 伊原木 聰一郎, 坂本 裕美, 小野 喜章, 増井 正典, 吉岡 徳枝, 西山 明慶, 佐々木 朗

    日本顎変形症学会雑誌   32 ( 2 )   165 - 165   2022年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本顎変形症学会  

    researchmap

  • 口腔癌のエクソソームを介した腫瘍進展機序の解明と新規治療戦略の開発に向けて 分子シャペロン搭載エクソソームの可能性

    小野 喜章, 江口 傑徳, 十川 千春, 奥舎 有加, 岡元 邦彰, 佐々木 朗

    口腔組織培養学会誌   31 ( 1 )   33 - 34   2022年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本口腔組織培養学会  

    researchmap

  • 岡山大学病院口腔外科口腔顎顔面外科部門で経験した口底部迷入歯に関する臨床的検討

    増井 正典, 伊原木 聰一郎, 國定 勇希, 小畑 協一, 小野 喜章, 竜門 省二, 佐々木 朗

    日本口腔診断学会雑誌   35 ( 1 )   115 - 115   2022年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔診断学会  

    researchmap

  • Reproduction of the Antitumor Effect of Cisplatin and Cetuximab Using a Three-dimensional Spheroid Model in Oral Cancer. 国際誌

    Kisho Ono, Kohei Sato, Tomoya Nakamura, Yume Yoshida, Shogo Murata, Kunihiro Yoshida, Hideka Kanemoto, Koki Umemori, Hotaka Kawai, Kyoichi Obata, Shoji Ryumon, Kazuaki Hasegawa, Yuki Kunisada, Tatsuo Okui, Soichiro Ibaragi, Hitoshi Nagatsuka, Akira Sasaki

    International journal of medical sciences   19 ( 8 )   1320 - 1333   2022年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background/Aim: Cancer research has been conducted using cultured cells as part of drug discovery testing, but conventional two-dimensional culture methods are unable to reflect the complex tumor microenvironment. On the other hand, three-dimensional cultures have recently been attracting attention as in vitro models that more closely resemble the in vivo physiological environment. The purpose of this study was to establish a 3D culture method for oral cancer and to verify its practicality. Materials and Methods: Three-dimensional cultures were performed using several oral cancer cell lines. Western blotting was used for protein expression analysis of the collected cell masses (spheroids), and H-E staining was used for structural observation. The cultures were exposed to cisplatin and cetuximab and the morphological changes of spheroids over time and the expression changes of target proteins were compared. Results: Each cell line formed spheroidal cell aggregates and showed enhancement of cell adhesion molecules over time. H-E staining showed tumor tissue-like structures specific to each cell line. Cisplatin showed concentration-dependent antitumor effects due to loss of cell adhesion and spheroid disruption in each cell line, while cetuximab exhibited antitumor effects that correlated with EGFR expression in each cell line. Conclusion: Spheroids made from oral cancer cell lines appeared to have tumor-like characteristics that may reflect their clinical significance. In the future, it may become possible to produce tumor spheroids from tissue samples of oral cancer patients, and then apply them to drug screening and to develop individualized diagnostic and treatment methods.

    DOI: 10.7150/ijms.74109

    PubMed

    researchmap

  • Resident stroma-secreted chemokine CCL2 governs myeloid-derived suppressor cells in the tumor microenvironment. 国際誌

    May Wathone Oo, Hotaka Kawai, Kiyofumi Takabatake, Shuta Tomida, Takanori Eguchi, Kisho Ono, Qiusheng Shan, Toshiaki Ohara, Saori Yoshida, Haruka Omori, Shintaro Sukegawa, Keisuke Nakano, Kuniaki Okamoto, Akira Sasaki, Hitoshi Nagatsuka

    JCI insight   7 ( 1 )   2021年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Accumulating evidence has shown that cancer stroma and bone marrow-derived cells (BMDCs) in the tumor microenvironment (TME) play vital roles in tumor progression. However, the mechanism by which oral cancer stroma recruits any particular subset of BMDCs remains largely unknown. Here we sought to identify the subset of BMDCs that is recruited by cancer stroma. We established a sequential transplantation model in BALB/c nude mice, including (i) bone marrow transplantation of GFP-expressing cells and (ii) co-xenografting of patient-derived stroma (two cases, designated PDS1 and PDS2) with oral cancer cells (HSC-2). As controls, xenografting was performed with HSC-2 alone or in combination with normal human dermal fibroblasts (HDF). PDS1, PDS2, and HDF all promoted BMDCs migration in vitro and recruitment in vivo. Multicolor immunofluorescence revealed that the PDS co-xenografts recruited Arginase-1/CD11b/GR1/GFP quadruple-positive cells, which are myeloid-derived suppressor cells (MDSCs), to the TME, whereas the HDF co-xenograft did not. Screening using microarrays revealed that PDS1 and PDS2 expressed CCL2 mRNA (encoding C-C motif chemokine ligand 2) at higher levels than did HDF. Indeed, PDS xenografts contained significantly higher proportions of CCL2-positive stromal cells and CCR2/Arginase-1/CD11b/GR1 quadruple-positive MDSCs (as receiver cells) than the HDF co-xenograft. Consistently, a CCL2 synthesis inhibitor and a CCR2 antagonist significantly inhibited the PDS-driven migration of BM cells in vitro. Furthermore, intraperitoneal injection of the CCR2 antagonist to the PDS xenograft models significantly reduced the CCR2/Arginase-1/CD11b/GR1 quadruple-positive MDSCs infiltration to the TME. In conclusion, oral cancer stroma-secreted CCL2 is a key signal for recruiting CCR2-positive MDSCs from bone marrow to the TME.

    DOI: 10.1172/jci.insight.148960

    PubMed

    researchmap

  • 岡山大学病院口腔外科口腔顎顔面外科部門で経験した口底部迷入歯に関する臨床的検討

    増井 正典, 伊原木 聰一郎, 國定 勇希, 小畑 協一, 小野 喜章, 竜門 省二, 佐々木 朗

    日本口腔内科学会雑誌   27 ( 2 )   115 - 115   2021年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • 3次元培養システムを用いた口腔癌の薬剤応答性に対する新規in vitroモデルの検証(A novel 3-dimensional culture system as an in vitro model for drug responsiveness of oral cancer)

    佐藤 晃平, 小野 喜章, 河合 穂高, 中野 敬介, 長塚 仁, 佐々木 朗

    Journal of Oral Biosciences Supplement   2021   200 - 200   2021年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)歯科基礎医学会  

    researchmap

  • Extracellular vesicles of P. gingivalis-infected macrophages induce lung injury. 国際誌

    Kayo Yoshida, Kaya Yoshida, Natsumi Fujiwara, Mariko Seyama, Kisho Ono, Hotaka Kawai, Jiajie Guo, Ziyi Wang, Yao Weng, Yaqiong Yu, Yoko Uchida-Fukuhara, Mika Ikegame, Akira Sasaki, Hitoshi Nagatsuka, Hiroshi Kamioka, Hirohiko Okamura, Kazumi Ozaki

    Biochimica et biophysica acta. Molecular basis of disease   1867 ( 11 )   166236 - 166236   2021年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Periodontal diseases are common inflammatory diseases that are induced by infection with periodontal bacteria such as Porphyromonas gingivalis (Pg). The association between periodontal diseases and many types of systemic diseases has been demonstrated; the term "periodontal medicine" is used to describe how periodontal infection/inflammation may impact extraoral health. However, the molecular mechanisms by which the factors produced in the oral cavity reach multiple distant organs and impact general health have not been elucidated. Extracellular vesicles (EVs) are nano-sized spherical structures secreted by various types of cells into the tissue microenvironment, and influence pathophysiological conditions by delivering their cargo. However, a detailed understanding of the effect of EVs on periodontal medicine is lacking. In this study, we investigated whether EVs derived from Pg-infected macrophages reach distant organs in mice and influence the pathophysiological status. EVs were isolated from human macrophages, THP-1 cells, infected with Pg. We observed that EVs from Pg-infected THP-1 cells (Pg-inf EVs) contained abundant core histone proteins such as histone H3 and translocated to the lungs, liver, and kidneys of mice. Pg-inf EVs also induced pulmonary injury, including edema, vascular congestion, inflammation, and collagen deposition causing alveoli destruction. The Pg-inf EVs or the recombinant histone H3 activated the NF-κB pathway, leading to increase in the levels of pro-inflammatory cytokines in human lung epithelial A549 cells. Our results suggest a possible mechanism by which EVs produced in periodontal diseases contribute to the progression of periodontal medicine.

    DOI: 10.1016/j.bbadis.2021.166236

    PubMed

    researchmap

  • Comparative Study on Epstein-Barr Virus-Positive Mucocutaneous Ulcer and Methotrexate-Associated Lymphoproliferative Disorders Developed in the Oral Mucosa: A Case Series of 10 Patients and Literature Review. 国際誌

    Kyoichi Obata, Tatsuo Okui, Sawako Ono, Koki Umemori, Shoji Ryumon, Kisho Ono, Mayumi Yao, Norie Yoshioka, Soichiro Ibaragi, Akira Sasaki

    Diagnostics (Basel, Switzerland)   11 ( 8 )   2021年7月

     詳細を見る

    記述言語:英語  

    Methotrexate-associated lymphoproliferative disorder (MTX-LPD) is an iatrogenic immunodeficiency-associated lymphoproliferative disorder that occurs mainly with MTX use. This disorder has been associated with Epstein-Barr virus (EBV) infection. In 2017, the WHO newly defined the disease concept of EBV-positive mucocutaneous ulcer (EBV-MCU) as a good-prognosis EBV-related disease. Here, we report 10 cases of MTX-LPD or EBV-MCU in the oral mucosa. This retrospective, observational study was conducted with MTX-LPD or EBV-MCU in the oral mucosa patients who visited us during the nine year period from 2012 to 2021. We gathered the basic information, underlying disease, histopathological evaluation, treatment and prognosis for the subjects. All were being treated with MTX for rheumatoid arthritis. EBV infection was positive in all cases by immunohistochemistry. A complete or partial response was obtained in all cases with the withdrawal of MTX. Our results suggests that the most common risk factor for developing EBV-MCU is the use of immunosuppressive drugs. The most common site of onset is the oral mucosa, which may be attributed to the mode of EBV infection and the high incidence of chronic irritation of the oral mucosa. A small number of patients had been diagnosed with MTX-LPD, but we consider that these cases were EBV-MCU based on our study.

    DOI: 10.3390/diagnostics11081375

    PubMed

    researchmap

  • HMGB1は進行期頭頸部癌モデルマウスにおいて癌性骨痛を誘発する

    中村 友哉, 奥井 達雄, 竜門 省二, 小野 喜章, 小畑 協一, 増井 正典, 伊原木 聰一郎, 佐々木 朗

    日本口腔科学会雑誌   70 ( 2 )   128 - 128   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本口腔科学会  

    researchmap

  • Clinical anatomy of the inferior labial gland: a narrative review

    Daniel Shen, Kisho Ono, Quang Do, Hiroe Ohyama, Ken Nakamura, Kyoichi Obata, Soichiro Ibaragi, Koichi Watanabe, R. Shane Tubbs, Joe Iwanaga

    GLAND SURGERY   10 ( 7 )   2284 - 2292   2021年7月

     詳細を見る

  • High mobility group box 1は口腔扁平上皮癌の骨破壊を誘発する

    坂本 裕美, 奥井 達雄, 竜門 省二, 中村 友哉, 國定 勇希, 増井 正典, 小野 喜章, 小畑 協一, 伊原木 聰一郎, 佐々木 朗

    日本口腔科学会雑誌   70 ( 2 )   115 - 115   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本口腔科学会  

    researchmap

  • A case of langerhans cell histiocytosis of the mandible that spontaneously regressed after biopsy in a child 査読

    Kisho Ono, Tatsuo Okui, Yuki Kunisada, Kyoichi Obata, Masanori Masui, Shoji Ryumon, Soichiro Ibaragi, Tomoya Nakamura, Akira Sasaki

    Clinical Case Reports   9 ( 6 )   2021年6月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    DOI: 10.1002/ccr3.4321

    researchmap

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ccr3.4321

  • 悪性黒色腫に対する新規血管新生阻害薬terreinの抗腫瘍効果の検討

    伊原木 聰一郎, 小野 喜章, 小畑 協一, 増井 正典, 吉岡 徳枝, 佐々木 朗

    頭頸部癌   47 ( 2 )   228 - 228   2021年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭頸部癌学会  

    researchmap

  • 口腔領域に発生したEBV-positive mucocutaneous ulcerに関する統計学的検討

    小畑 協一, 伊原木 聰一郎, 小野 喜章, 増井 正典, 矢尾 真弓, 岸本 晃治, 吉岡 徳枝, 佐々木 朗

    頭頸部癌   47 ( 2 )   232 - 232   2021年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭頸部癌学会  

    researchmap

  • 根治的頸部郭清術後に後頭リンパ節転移をきたした舌癌の一例

    小野 喜章, 吉岡 徳枝, 小畑 協一, 増井 正典, 岸本 晃治, 伊原木 聰一郎, 長塚 仁, 佐々木 朗

    頭頸部癌   47 ( 2 )   234 - 234   2021年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭頸部癌学会  

    researchmap

  • 上顎圧下時の頬骨下陵部の骨連続性維持のためのLe Fort I型骨切り術 軒先型骨切り術

    西山 明慶, 吉岡 徳枝, 小畑 協一, 國定 勇希, 小野 喜章, 村瀬 友理香, 竜門 省二, 岸本 晃治, 伊原木 聰一郎, 佐々木 朗

    日本顎変形症学会雑誌   31 ( 2 )   96 - 96   2021年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本顎変形症学会  

    researchmap

  • Correction to: Duplication of the external jugular vein: a language barrier of database search in classic anatomical studies. 査読 国際誌

    Kisho Ono, Norie Yoshioka, Dany Hage, Soichiro Ibaragi, R Shane Tubbs, Joe Iwanaga

    Surgical and radiologic anatomy : SRA   43 ( 10 )   1729 - 1730   2021年4月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語  

    DOI: 10.1007/s00276-021-02743-4

    PubMed

    researchmap

  • 切除後に再発を認めた舌のhobnail hemangiomaの1例

    國定 勇希, 槇野 隆秀, 伊原木 聰一郎, 熊谷 智代, 小野 喜章, 佐々木 朗

    日本口腔外科学会雑誌   67 ( 4 )   239 - 242   2021年4月

  • 切除後に再発を認めた舌のhobnail hemangiomaの1例

    國定 勇希, 槇野 隆秀, 伊原木 聰一郎, 熊谷 智代, 小野 喜章, 佐々木 朗

    日本口腔外科学会雑誌   67 ( 4 )   239 - 242   2021年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本口腔外科学会  

    researchmap

  • Duplication of the external jugular vein: a language barrier of database search in classic anatomical studies. 査読 国際誌

    Kisho Ono, Norie Yoshioka, Dany Hage, Soichiro Ibaragi, R Shane Tubbs, Joe Iwanaga

    Surgical and radiologic anatomy : SRA   2021年2月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: Many anatomical variations of the superficial veins of the head and neck have been reported throughout the literature. Accordingly, anatomists and surgeons must have a comprehensive understanding of these variations to avoid confusion. Duplication of the external jugular vein (EJV) is occasionally observed during routine cadaveric dissections; however, this variation seems to be reported less often than actual experience suggests. Therefore, to gain a better understanding of its anatomical and clinical implications, an analysis of the available data should be available. Thus, in this article, we reviewed the current available literature for studies reporting duplication of the EJV. METHODS: We conducted a search using PubMed and Google Scholar with the following keywords: "duplication of the external jugular vein," "division of the external jugular vein," and "fenestration of the external jugular vein," "double external jugular vein," and "doubled external jugular vein." As a case illustration, we also describe a case of a duplicated EJV found during a right neck dissection of a female cadaver. RESULTS: Twenty sides across sixteen different studies were analyzed including the present case. All studies were published between 2009 and 2020. EJV division patterns were classified as either duplication, fenestration, fenestration followed by duplication, or double fenestrations. CONCLUSIONS: We have reviewed the literature regarding cases documenting duplication/fenestration of the EJV. As it is often difficult to find recent studies that report on classic anatomical variations, therefore, revisiting older articles and textbooks is necessary for achieving a "comprehensive" review, especially across different languages.

    DOI: 10.1007/s00276-021-02717-6

    PubMed

    researchmap

  • The HMGB1/RAGE axis induces bone pain associated with colonization of 4T1 mouse breast cancer in bone. 査読 国際誌

    Tatsuo Okui, Masahiro Hiasa, Shoji Ryumon, Kisho Ono, Yuki Kunisada, Soichiro Ibaragi, Akira Sasaki, G David Roodman, Fletcher A White, Toshiyuki Yoneda

    Journal of bone oncology   26   100330 - 100330   2021年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Bone pain is a common complication of breast cancer (BC) bone metastasis and is a major cause of increased morbidity and mortality. Although the mechanism of BC-associated bone pain (BCABP) remains poorly understood, involvement of BC products in the pathophysiology of BCABP has been proposed. Aggressive cancers secrete damage-associated molecular patterns (DAMPs) that bind to specific DAMP receptors and modulate cancer microenvironment. A prototypic DAMP, high mobility group box 1 (HMGB1), which acts as a ligand for the receptor for advanced glycation end products (RAGE) and toll-like receptors (TLRs), is increased in its expression in BC patients with poor outcomes. Here we show that 4T1 mouse BC cells colonizing bone up-regulate the expression of molecular pain markers, phosphorylated ERK1/2 (pERK) and pCREB, in the dorsal root ganglia (DRGs) innervating bone and induced BCABP as evaluated by hind-paw mechanical hypersensitivity. Importantly, silencing HMGB1 in 4T1 BC cells by shRNA reduced pERK and pCREB and BCABP with decreased HMGB1 levels in bone. Further, administration of a neutralizing antibody to HMGB1 or an antagonist for RAGE, FPS-ZM1, ameliorated pERK, pCREB and BCABP, while a TLR4 antagonist, TAK242, showed no effects. Consistent with these in vivo results, co-cultures of F11 sensory neuron-like cells with 4T1 BC cells in microfluidic culture platforms increased neurite outgrowth of F11 cells, which was blocked by HMGB1 antibody. Our results show that HMGB1 secreted by BC cells induces BCABP via binding to RAGE of sensory neurons and suggest that the HMGB1/RAGE axis may be a potential novel therapeutic target for BCABP.

    DOI: 10.1016/j.jbo.2020.100330

    PubMed

    researchmap

  • 顎骨壊死を伴ったEBV陽性皮膚粘膜潰瘍(EBV-MCU)の2例

    竜門 省二, 岸本 晃治, 奥井 達雄, 吉岡 徳枝, 小畑 協一, 國定 勇希, 増井 正典, 小野 喜章, 伊原木 聰一郎, 佐々木 朗

    日本口腔診断学会雑誌   34 ( 1 )   71 - 71   2021年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔診断学会  

    researchmap

  • Surgical resection of a giant peripheral ossifying fibroma in mouth floor managed with fiberscopic intubation. 査読 国際誌

    Tatsuo Okui, Soichiro Ibaragi, Kisho Ono, Kazuaki Hasegawa, Akira Sasaki

    Clinical case reports   9 ( 1 )   180 - 184   2021年1月

     詳細を見る

    記述言語:英語  

    Tracheal intubation for general anesthesia can sometimes be difficult in patients with a large mass in the mouth floor. Preoperative evaluation of the patient's airway is most important when treating large oral disease.

    DOI: 10.1002/ccr3.3494

    PubMed

    researchmap

  • Incidence and characteristics of medical emergencies related to dental treatment: a retrospective single‐center study 査読 国際誌

    Kyoichi Obata, Hiromichi Naito, Hiromasa Yakushiji, Takafumi Obara, Kisho Ono, Tsuyoshi Nojima, Kohei Tsukahara, Taihei Yamada, Akira Sasaki, Atsunori Nakao

    Acute Medicine & Surgery   8 ( 1 )   e651   2021年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    AIM: Although uncommon, medical emergencies arise in general dental practice. Inadequate data on their severity and frequency makes targeting medical education for general dental practitioners difficult. This also makes planning for unexpected events challenging for practitioners and makes collaborating with emergency physicians burdensome. We aimed to clarify the incidence and characteristics of a dental outpatient department's medical emergencies. METHODS: This single-center, retrospective, observational study was undertaken with patients who visited the dental outpatient department of Okayama University Hospital during the 8-year period. The primary outcome of the study was to identify the incidence and characteristics of medical emergencies in the dental outpatient department. Then we examined the timing of medical emergencies, administered medications, and final disposition (home/admission). RESULTS: During the period, 1,146,929 patients were enrolled. Forty-two patients (0.0037%) were consulted as medical emergencies. More than 60% of the incidents were vasovagal syncope, and dehydration and hypoglycemia were the second most prevalent at 9.5%. The most common types of dental treatments were tooth extraction (45.2%), followed by general dental treatment (28.6%), and other dental surgery such as implant placement (14.3%). Types of medical emergencies occurred equally before, during, and after dental treatment. Antihypertensive agents, sedatives, or glucose were used. For patients with emergencies, 90.5% recovered during the day and returned home, and 9.5% were hospitalized. CONCLUSION: The incidence of medical emergencies was low in our dental outpatient department. Knowledge of basic management principles, regular education for emergency care, and practicing first aid skills are mandatory for safe patient management.

    DOI: 10.1002/ams2.651

    PubMed

    researchmap

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ams2.651

  • High mobility group box 1 induces bone pain associated with bone invasion in a mouse model of advanced head and neck cancer. 査読 国際誌

    Tomoya Nakamura, Tatsuo Okui, Kazuaki Hasegawa, Shoji Ryumon, Soichiro Ibaragi, Kisho Ono, Yuki Kunisada, Kyoichi Obata, Masanori Masui, Tsuyoshi Shimo, Akira Sasaki

    Oncology reports   44 ( 6 )   2547 - 2558   2020年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Advanced head and neck cancer (HNC) can invade facial bone and cause bone pain, thus posing a significant challenge to the quality of life of patients presenting with advanced HNC. The present study was designed to investigate HNC bone pain (HNC‑BP) in an intratibial mouse xenograft model that utilized an HNC cell line (SAS cells). These mice develop HNC‑BP that is associated with an expression of phosphorylated ERK1/2 (pERK1/2), which is a molecular indicator of neuron excitation in dorsal root ganglia (DRG) sensory neurons. Our experiments demonstrated that the inhibition of high mobility group box 1 (HMGB1) by short hairpin (shRNA) transduction, HMGB1 neutralizing antibody, and HMGB1 receptor antagonist suppressed the HNC‑BP and the pERK1/2 expression in DRG. It was also observed that HNC‑derived HMGB1 increased the expression of the acid‑sensing nociceptor, transient receptor potential vanilloid 1 (TRPV1), which is a major cause of osteoclastic HNC‑BP in DRG. Collectively, our results demonstrated that HMGB1 originating in HNC evokes HNC‑BP via direct HMGB1 signaling and hypersensitization for the acid environment in sensory neurons.

    DOI: 10.3892/or.2020.7788

    PubMed

    researchmap

  • A case of oral cancer with delayed occipital lymph node metastasis: Case report. 査読 国際誌

    Kisho Ono, Norie Yoshioka, Masanori Masui, Kyoichi Obata, Yuki Kunisada, Tatsuo Okui, Soichiro Ibaragi, Hotaka Kawai, Hitoshi Nagatsuka, Akira Sasaki

    Clinical case reports   8 ( 12 )   2469 - 2475   2020年12月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語  

    Consideration of unexpected metastasis in patients who have undergone neck dissection with advanced tumors must be anticipated with careful follow-up.

    DOI: 10.1002/ccr3.3086

    PubMed

    researchmap

  • 侵襲性歯周炎の血液診断バイオマーカーとしての細胞外小胞由来マイクロRNAの探索

    河本 美奈, 山本 直史, 河村 麻理, 森 彩乃, 山城 圭介, 大森 一弘, 小野 喜章, 江口 傑徳, 十川 千春, 高柴 正悟

    岡山歯学会雑誌   39 ( 2 )   35 - 36   2020年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:岡山歯学会  

    researchmap

  • High-mobility group box 1 induces bone destruction associated with advanced oral squamous cancer via RAGE and TLR4. 査読 国際誌

    Yumi Sakamoto, Tatsuo Okui, Toshiyuki Yoneda, Shoji Ryumon, Tomoya Nakamura, Hotaka Kawai, Yuki Kunisada, Soichiro Ibaragi, Masanori Masui, Kisho Ono, Kyoichi Obata, Tsuyoshi Shimo, Akira Sasaki

    Biochemical and biophysical research communications   531 ( 3 )   422 - 430   2020年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Bone destruction of maxillary and mandibular bone by invasive oral squamous cell cancer (OSCC) raises various problems in the management of patients, resulting in poor outcomes and survival. However, the mechanism behind bone destruction by OSCC remains unclear. High-mobility group box 1 (HMGB1), a highly conserved ubiquitous nuclear non-histone DNA-binding protein, has been demonstrated to be secreted by aggressive cancers and regulate osteoclastogenesis, a central player during bone destruction. We therefore reasoned that HMGB1 secreted by OSCCs contributes to bone destruction. Our results showed that HMGB1 is produced by human cell lines of OSCC and promotes osteoclastogenesis via up-regulation of the expression of receptor activator of nuclear factor kappa-Β ligand in osteoblasts and osteocytes, and consequently osteoclastic bone destruction in mice. Further, we found that these actions of HMGB1 are mediated via the receptor for advanced glycation end products and toll-like receptors. These findings suggest that HMGB1 of OSCC and its down-stream signal pathways are potential targets for the treatment of bone destruction associated with advanced OSCC.

    DOI: 10.1016/j.bbrc.2020.07.120

    PubMed

    researchmap

  • Outer membrane vesicles derived from Porphyromonas gingivalis induced cell death with disruption of tight junctions in human lung epithelial cells. 査読 国際誌

    Yuhan He, Noriko Shiotsu, Yoko Uchida-Fukuhara, Jiajie Guo, Yao Weng, Mika Ikegame, Ziyi Wang, Kisho Ono, Hiroshi Kamioka, Yasuhiro Torii, Akira Sasaki, Kaya Yoshida, Hirohiko Okamura

    Archives of oral biology   118   104841 - 104841   2020年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVE: Porphyromonas gingivalis (P. gingivalis) is a major bacterium responsible for the progression of periodontitis. P. gingivalis produces small vesicles called outer membrane vesicles (OMVs) containing virulence factors. Increasing evidence suggests a close relationship between periodontitis and respiratory system diseases, such as aspiration pneumonia. However, little is known about whether P. gingivalis OMVs give rise to the impediment of lung epithelial cells. We investigated the effect of the OMVs on cell viability and tight junctions of lung epithelial cells. DESIGN: Human lung epithelial A549 cells were treated with P. gingivalis OMVs. Cell viability was evaluated, and cell morphology was examined using scanning electron and phase contrast microscopies. To detect apoptosis induced by P. gingivalis OMVs, activation of caspase-3 and poly ADP-ribose polymerase (PARP) cleavage was examined by using Western blotting. Immunocytochemistry was performed to stain tight junction proteins. RESULTS: P. gingivalis OMVs decreased cell viability in A549 cells in a dose- and time-dependent manner. Microscopic analysis revealed that the OMVs induced morphological changes leading to irregular cell membrane structures. The OMVs caused cell shrinkage, membrane blebbing, and cytoplasmic expulsion in a dose-dependent manner. Western blot analysis showed the OMVs induced caspase-3 activation and PARP cleavage. Treatment with the OMVs disrupted the intact distributions of tight junction proteins. CONCLUSIONS: These results indicate that P. gingivalis OMVs induced cell death by destroying the barrier system in lung epithelial cells. Our present study raises the possibility that P. gingivalis OMVs is an important factor in the engagement of periodontitis with respiratory system diseases.

    DOI: 10.1016/j.archoralbio.2020.104841

    PubMed

    researchmap

  • ニコチンが口腔癌細胞に与える影響の検討

    伊原木 聰一郎, 清水 理恵子, 奥井 達雄, 高畠 清文, 河合 穂高, 小野 喜章, 長塚 仁, 佐々木 朗

    日本口腔科学会雑誌   69 ( 3 )   235 - 235   2020年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本口腔科学会  

    researchmap

  • 頬粘膜に発生した腺房細胞癌の1例 本邦における小唾液腺腺房細胞癌に関する文献的検討 査読

    小畑 協一, 岸本 晃治, 小野 喜章, 河合 穂高, 柴田 茜, 奥井 達雄, 矢尾 真弓, 伊原木 聰一郎, 佐々木 朗

    日本口腔腫瘍学会誌   32 ( 3 )   77 - 82   2020年9月

  • Outer membrane vesicles of Porphyromonas gingivalis attenuate insulin sensitivity by delivering gingipains to the liver. 査読 国際誌

    Mariko Seyama, Kaya Yoshida, Kayo Yoshida, Natsumi Fujiwara, Kisho Ono, Takanori Eguchi, Hotaka Kawai, Jiajie Guo, Yao Weng, Yuan Haoze, Kenta Uchibe, Mika Ikegame, Akira Sasaki, Hitoshi Nagatsuka, Kuniaki Okamoto, Hirohiko Okamura, Kazumi Ozaki

    Biochimica et biophysica acta. Molecular basis of disease   1866 ( 6 )   165731 - 165731   2020年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Outer membrane vesicles (OMVs) are nanosized particles derived from the outer membrane of gram-negative bacteria. Oral bacterium Porphyromonas gingivalis (Pg) is known to be a major pathogen of periodontitis that contributes to the progression of periodontal disease by releasing OMVs. The effect of Pg OMVs on systemic diseases is still unknown. To verify whether Pg OMVs affect the progress of diabetes mellitus, we analyzed the cargo proteins of vesicles and evaluated their effect on hepatic glucose metabolism. Here, we show that Pg OMVs were equipped with Pg-derived proteases gingipains and translocated to the liver in mice. In these mice, the hepatic glycogen synthesis in response to insulin was decreased, and thus high blood glucose levels were maintained. Pg OMVs also attenuated the insulin-induced Akt/glycogen synthase kinase-3 β (GSK-3β) signaling in a gingipain-dependent fashion in hepatic HepG2 cells. These results suggest that the delivery of gingipains mediated by Pg OMV elicits changes in glucose metabolisms in the liver and contributes to the progression of diabetes mellitus.

    DOI: 10.1016/j.bbadis.2020.165731

    PubMed

    researchmap

  • Triple knockdown of CDC37, HSP90-alpha and HSP90-beta diminishes extracellular vesicles-driven malignancy events and macrophage M2 polarization in oral cancer. 査読 国際誌

    Kisho Ono, Chiharu Sogawa, Hotaka Kawai, Manh Tien Tran, Eman A Taha, Yanyin Lu, May Wathone Oo, Yuka Okusha, Hirohiko Okamura, Soichiro Ibaragi, Masaharu Takigawa, Ken-Ichi Kozaki, Hitoshi Nagatsuka, Akira Sasaki, Kuniaki Okamoto, Stuart K Calderwood, Takanori Eguchi

    Journal of extracellular vesicles   9 ( 1 )   1769373 - 1769373   2020年5月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Evidence has been accumulating to indicate that extracellular vesicles (EVs), including exosomes, released by cancer cells can foster tumour progression. The molecular chaperones - CDC37, HSP90α and HSP90β play key roles in cancer progression including epithelial-mesenchymal transition (EMT), although their contribution to EVs-mediated cell-cell communication in tumour microenvironment has not been thoroughly examined. Here we show that triple depletion of the chaperone trio attenuates numerous cancer malignancy events exerted through EV release. Metastatic oral cancer-derived EVs (MEV) were enriched with HSP90α HSP90β and cancer-initiating cell marker CD326/EpCAM. Depletion of these chaperones individually induced compensatory increases in the other chaperones, whereas triple siRNA targeting of these molecules markedly diminished the levels of the chaperone trio and attenuated EMT. MEV were potent agents in initiating EMT in normal epithelial cells, a process that was attenuated by the triple chaperone depletion. The migration, invasion, and in vitro tumour initiation of oral cancer cells were significantly promoted by MEV, while triple depletion of CDC37/HSP90α/β reversed these MEV-driven malignancy events. In metastatic oral cancer patient-derived tumours, HSP90β was significantly accumulated in infiltrating tumour-associated macrophages (TAM) as compared to lower grade oral cancer cases. HSP90-enriched MEV-induced TAM polarization to an M2 phenotype, a transition known to support cancer progression, whereas the triple chaperone depletion attenuated this effect. Mechanistically, the triple chaperone depletion in metastatic oral cancer cells effectively reduced MEV transmission into macrophages. Hence, siRNA-mediated knockdown of the chaperone trio (CDC37/HSP90α/HSP90β) could potentially be a novel therapeutic strategy to attenuate several EV-driven malignancy events in the tumour microenvironment. Abbreviations: CDC37: cell division control 37; EMT: epithelial-mesenchymal transmission; EV: extracellular vesicles; HNSCC: head and neck squamous cell carcinoma; HSP90: heat shock protein 90; TAM: tumour-associated macrophage.

    DOI: 10.1080/20013078.2020.1769373

    PubMed

    researchmap

  • Extracellular Vesicles Enriched with Moonlighting Metalloproteinase Are Highly Transmissive, Pro-Tumorigenic, and Trans-Activates Cellular Communication Network Factor (CCN2/CTGF): CRISPR against Cancer. 査読 国際誌

    Yuka Okusha, Takanori Eguchi, Manh T Tran, Chiharu Sogawa, Kaya Yoshida, Mami Itagaki, Eman A Taha, Kisho Ono, Eriko Aoyama, Hirohiko Okamura, Ken-Ichi Kozaki, Stuart K Calderwood, Masaharu Takigawa, Kuniaki Okamoto

    Cancers   12 ( 4 )   2020年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Matrix metalloproteinase 3 (MMP3) plays multiple roles in extracellular proteolysis as well as intracellular transcription, prompting a new definition of moonlighting metalloproteinase (MMP), according to a definition of protein moonlighting (or gene sharing), a phenomenon by which a protein can perform more than one function. Indeed, connective tissue growth factor (CTGF, aka cellular communication network factor 2 (CCN2)) is transcriptionally induced as well as cleaved by MMP3. Moreover, several members of the MMP family have been found within tumor-derived extracellular vesicles (EVs). We here investigated the roles of MMP3-rich EVs in tumor progression, molecular transmission, and gene regulation. EVs derived from a rapidly metastatic cancer cell line (LuM1) were enriched in MMP3 and a C-terminal half fragment of CCN2/CTGF. MMP3-rich, LuM1-derived EVs were disseminated to multiple organs through body fluid and were pro-tumorigenic in an allograft mouse model, which prompted us to define LuM1-EVs as oncosomes in the present study. Oncosome-derived MMP3 was transferred into recipient cell nuclei and thereby trans-activated the CCN2/CTGF promoter, and induced CCN2/CTGF production in vitro. TRENDIC and other cis-elements in the CCN2/CTGF promoter were essential for the oncosomal responsivity. The CRISPR/Cas9-mediated knockout of MMP3 showed significant anti-tumor effects such as the inhibition of migration and invasion of tumor cells, and a reduction in CCN2/CTGF promoter activity and fragmentations in vitro. A high expression level of MMP3 or CCN2/CTGF mRNA was prognostic and unfavorable in particular types of cancers including head and neck, lung, pancreatic, cervical, stomach, and urothelial cancers. These data newly demonstrate that oncogenic EVs-derived MMP is a transmissive trans-activator for the cellular communication network gene and promotes tumorigenesis at distant sites.

    DOI: 10.3390/cancers12040881

    PubMed

    researchmap

  • Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells. 査読 国際誌

    Takanori Eguchi, Chiharu Sogawa, Kisho Ono, Masaki Matsumoto, Manh Tien Tran, Yuka Okusha, Benjamin J Lang, Kuniaki Okamoto, Stuart K Calderwood

    Cells   9 ( 3 )   2020年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Tumor cells exhibit therapeutic stress resistance-associated secretory phenotype involving extracellular vesicles (EVs) such as oncosomes and heat shock proteins (HSPs). Such a secretory phenotype occurs in response to cell stress and cancer therapeutics. HSPs are stress-responsive molecular chaperones promoting proper protein folding, while also being released from cells with EVs as well as a soluble form known as alarmins. We have here investigated the secretory phenotype of castration-resistant prostate cancer (CRPC) cells using proteome analysis. We have also examined the roles of the key co-chaperone CDC37 in the release of EV proteins including CD9 and epithelial-to-mesenchymal transition (EMT), a key event in tumor progression. EVs derived from CRPC cells promoted EMT in normal prostate epithelial cells. Some HSP family members and their potential receptor CD91/LRP1 were enriched at high levels in CRPC cell-derived EVs among over 700 other protein types found by mass spectrometry. The small EVs (30-200 nm in size) were released even in a non-heated condition from the prostate cancer cells, whereas the EMT-coupled release of EVs (200-500 nm) and damaged membrane vesicles with associated HSP90α was increased after heat shock stress (HSS). GAPDH and lactate dehydrogenase, a marker of membrane leakage/damage, were also found in conditioned media upon HSS. During this stress response, the intracellular chaperone CDC37 was transcriptionally induced by heat shock factor 1 (HSF1), which activated the CDC37 core promoter, containing an interspecies conserved heat shock element. In contrast, knockdown of CDC37 decreased EMT-coupled release of CD9-containing vesicles. Triple siRNA targeting CDC37, HSP90α, and HSP90β was required for efficient reduction of this chaperone trio and to reduce tumorigenicity of the CRPC cells in vivo. Taken together, we define "stressome" as cellular stress-induced all secretion products, including EVs (200-500 nm), membrane-damaged vesicles and remnants, and extracellular HSP90 and GAPDH. Our data also indicated that CDC37 is crucial for the release of vesicular proteins and tumor progression in prostate cancer.

    DOI: 10.3390/cells9030755

    PubMed

    researchmap

  • A Novel Model of Cancer Drug Resistance: Oncosomal Release of Cytotoxic and Antibody-Based Drugs. 査読 国際誌

    Takanori Eguchi, Eman Ahmed Taha, Stuart K Calderwood, Kisho Ono

    Biology   9 ( 3 )   2020年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Extracellular vesicles (EVs), such as exosomes or oncosomes, often carry oncogenic molecules derived from tumor cells. In addition, accumulating evidence indicates that tumor cells can eject anti-cancer drugs such as chemotherapeutics and targeted drugs within EVs, a novel mechanism of drug resistance. The EV-releasing drug resistance phenotype is often coupled with cellular dedifferentiation and transformation in cells undergoing epithelial-mesenchymal transition (EMT), and the adoption of a cancer stem cell phenotype. The release of EVs is also involved in immunosuppression. Herein, we address different aspects by which EVs modulate the tumor microenvironment to become resistant to anticancer and antibody-based drugs, as well as the concept of the resistance-associated secretory phenotype (RASP).

    DOI: 10.3390/biology9030047

    PubMed

    researchmap

  • Extracellular Oncosomes Rich in Moonlighting Metalloproteinase (MMP3) Are Transmissive, Pro-Tumorigenic, and Induces Cellular Communication Network Factor 2 (CCN2/CTGF): CRISPR against Cancer

    Yuka Okusha, Takanori Eguchi, Manh Tien Tran, Chiharu Sogawa, Kaya Yoshida, Mami Itagaki, Eman Ahmed Taha, Kisho Ono, Eriko Aoyama, Hirohiko Okamura, Ken-ichi Kozaki, Stuart K. Calderwood, Masaharu Takigawa, Kuniaki Okamoto

    Preprints   doi: 10.20944/preprints202002.0281.v1   2020年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.20944/preprints202002.0281.v1

    researchmap

  • CDC37 and HSP90 are Essential for Stressome Release and Tumor Progression in Resistant Prostate Cancer

    Takanori Eguchi, Chiharu Sogawa, Kisho Ono, Masaki Matsumoto, Manh Tien Tran, Yuka Okusha, Benjamin Lang, Kuniaki Okamoto, Stuart Calderwood

    2020年2月

     詳細を見る

    出版者・発行元:MDPI AG  

    Tumor cells exhibit a resistance-associated secretory phenotype involving extracellular vesicles (EVs) and heat shock proteins (HSPs). This response occurs in response to cell stress and cancer therapeutics. HSPs are stress-responsive molecular chaperones promoting proper protein folding, while also being released from cells with EVs as well as in free form as alarmins. We have here investigated the secretory phenotype of castration-resistant prostate cancer (CRPC) cells using proteome analysis. We have also examined the roles of the key co-chaperone CDC37 in stressome release, epithelial-to-mesenchymal transition (EMT), and tumor progression. A number of HSP family members and their common receptor CD91/LRP1 were enriched at high levels in CRPC cell-derived EVs among over 700 other protein species. The small EVs (30 to 200 nm in size, potentially exosomes) were released even in a non-heated condition from the prostate cancer cells, whereas EMT-coupled release of EVs (200 to 500 nm, likely ectosomes) with associated HSP90&amp;alpha; was increased after heat shock stress (HSS). Lactate dehydrogenase, a marker of membrane leakage/damage of cells, was also released upon HSS from the prostate cancer cells. During this stress response, intracellular CDC37 was also transcriptionally inducible by heat shock factor 1, and knockdown of CDC37 decreased EMT-coupled release of EVs. Triple knockdown of CDC37, HSP90&amp;alpha;, and HSP90&amp;beta; was required for efficient reduction of the chaperone trio and to reduce tumorigenicity of the CRPC cells in vivo. Taken together, the data indicated that CDC37 and HSP90 are essential for stressome release and for tumorigenesis in resistant cancer.

    DOI: 10.20944/preprints202002.0148.v1

    researchmap

  • Exosome Release of Drugs: Coupling with Epithelial-Mesenchymal Transition

    Takanori Eguchi, Kisho Ono, Stuart Calderwood, Kuniaki Okamoto

    2019年12月

     詳細を見る

    出版者・発行元:MDPI AG  

    Extracellular vesicles (EVs), such as exosomes or oncosomes are released with molecules unfavorable for survival from cells. In addition, accumulating evidence has shown that tumor cells often eject anti-cancer drugs such as chemotherapeutics and targeted drugs within EVs, a novel mechanism of drug resistance. The EV-releasing, drug resistance phenotype is often coupled with cellular dedifferentiation and transformation, cells undergoing epithelial-mesenchymal transition (EMT) and taking on a cancer stem cell phenotype. Recent studies have shown that the release of EVs is also involved in immunosuppression. The concept of the resistance-associated secretory phenotype (RASP) is reviewed herein.

    DOI: 10.20944/preprints201912.0386.v1

    researchmap

  • A Reporter System Evaluates Tumorigenesis, Metastasis, β-catenin/MMP Regulation, and Druggability. 査読 国際誌

    Chiharu Sogawa, Takanori Eguchi, Yuka Okusha, Kisho Ono, Kazumi Ohyama, Motoharu Iizuka, Ryu Kawasaki, Yusaku Hamada, Masaharu Takigawa, Norio Sogawa, Kuniaki Okamoto, Ken-Ichi Kozaki

    Tissue engineering. Part A   25 ( 19-20 )   1413 - 1425   2019年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Cancer invasion, metastasis, and therapy resistance are the crucial phenomena in cancer malignancy. The high expression of matrix metalloproteinase 9 (MMP9) is a biomarker as well as a causal factor of cancer invasiveness and metastatic activity. However, a regulatory mechanism underlying MMP9 expression in cancer is not clarified yet. In addition, a new strategy for anticancer drug discovery is becoming an important clue. In the present study, we aimed (i) to develop a novel reporter system evaluating tumorigenesis, invasiveness, metastasis, and druggability with a combination of three-dimensional tumoroid model and Mmp9 promoter and (ii) to examine pharmacological actions of anticancer medications using this reporter system. High expression and genetic amplification of MMP9 were found in colon cancer cases. We found that proximal promoter sequences of MMP9 in murine and human contained conserved binding sites for transcription factors β-catenin/TCF/LEF, glucocorticoid receptor (GR), and nuclear factor kappa-B (NF-κB). The murine Mmp9 promoter (-569 to +19) was markedly activated in metastatic colon cancer cells and additionally activated by tumoroid formation and by β-catenin signaling stimulator lithium chloride. The Mmp9 promoter-driven fluorescent reporter cells enabled the monitoring of activities of MMP9/gelatinase, tumorigenesis, invasion, and metastasis in syngeneic transplantation experiments. We also demonstrated pharmacological actions as follows: dexamethasone and hydrocortisone, steroidal medications binding to GR, inhibited the Mmp9 promoter but did not inhibit tumorigenesis. On the contrary, antimetabolite 5-fluorouracil, a gold standard for colon cancer chemotherapy, inhibited tumoroid formation but did not inhibit Mmp9 promoter activity. Notably, antimalaria medication artesunate inhibited both tumorigenesis and the Mmp9 promoter in vitro, potentially through inhibition of β-catenin/TCF/LEF signaling. Thus, this novel reporter system enabled monitoring tumorigenesis, invasiveness, metastasis, key regulatory signalings such as β-catenin/MMP9 axis, and druggability. Impact Statement Cancer invasion and metastasis have been shown to be driven by matrix metalloproteinase 9 (MMP9), whose expression mechanism is not clarified yet. In addition, a new strategy for anticancer drug discovery is becoming important. We established a novel reporter system evaluating tumorigenesis, invasiveness, metastasis, and druggability with a combination of three-dimensional (3D) tumoroid model and Mmp9 promoter. Using this reporter system, we demonstrated pharmacological actions of anticancer medications such as antimetabolite 5-fluorouracil (5-FU) and antimalaria medication artesunate (ART), which inhibited both tumorigenesis and β-catenin/MMP regulatory signaling. Our study impacts the translational fields of oncology, drug discovery, and organoid model.

    DOI: 10.1089/ten.TEA.2018.0348

    PubMed

    researchmap

  • Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion. 査読 国際誌

    Eman A Taha, Kisho Ono, Takanori Eguchi

    International journal of molecular sciences   20 ( 18 )   2019年9月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Extracellular heat shock proteins (ex-HSPs) have been found in exosomes, oncosomes, membrane surfaces, as well as free HSP in cancer and various pathological conditions, also known as alarmins. Such ex-HSPs include HSP90 (α, β, Gp96, Trap1), HSP70, and large and small HSPs. Production of HSPs is coordinately induced by heat shock factor 1 (HSF1) and hypoxia-inducible factor 1 (HIF-1), while matrix metalloproteinase 3 (MMP-3) and heterochromatin protein 1 are novel inducers of HSPs. Oncosomes released by tumor cells are a major aspect of the resistance-associated secretory phenotype (RASP) by which immune evasion can be established. The concepts of RASP are: (i) releases of ex-HSP and HSP-rich oncosomes are essential in RASP, by which molecular co-transfer of HSPs with oncogenic factors to recipient cells can promote cancer progression and resistance against stresses such as hypoxia, radiation, drugs, and immune systems; (ii) RASP of tumor cells can eject anticancer drugs, targeted therapeutics, and immune checkpoint inhibitors with oncosomes; (iii) cytotoxic lipids can be also released from tumor cells as RASP. ex-HSP and membrane-surface HSP (mHSP) play immunostimulatory roles recognized by CD91+ scavenger receptor expressed by endothelial cells-1 (SREC-1)+ Toll-like receptors (TLRs)+ antigen-presenting cells, leading to antigen cross-presentation and T cell cross-priming, as well as by CD94+ natural killer cells, leading to tumor cytolysis. On the other hand, ex-HSP/CD91 signaling in cancer cells promotes cancer progression. HSPs in body fluids are potential biomarkers detectable by liquid biopsies in cancers and tissue-damaged diseases. HSP-based vaccines, inhibitors, and RNAi therapeutics are also reviewed.

    DOI: 10.3390/ijms20184588

    PubMed

    researchmap

  • A case of intraoral plasmablastic lymphoma spontaneously regressed after biopsy in HIV-negative patient 査読

    Kisho Ono, Tatsuo Okui, Soichiro Ibaragi, Hotaka Kawai, Kyoichi Obata, Mariko Fujita, Akira Sasaki

    Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology   31 ( 4 )   280 - 283   2019年7月

     詳細を見る

    担当区分:筆頭著者   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.ajoms.2019.03.012

    researchmap

  • Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma. 査読 国際誌

    Rieko Shimizu, Soichiro Ibaragi, Takanori Eguchi, Daisuke Kuwajima, Shinichi Kodama, Takashi Nishioka, Tatsuo Okui, Kyoichi Obata, Kiyofumi Takabatake, Hotaka Kawai, Kisho Ono, Kuniaki Okamoto, Hitoshi Nagatsuka, Akira Sasaki

    International journal of oncology   54 ( 1 )   283 - 294   2019年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Epidermal growth factor (EGF) is overexpressed in many cancers and is associated with worse prognosis. EGF binds to its cell surface receptor (EGFR), which induces EGFR phosphorylation. Phosphorylated EGFR (p‑EGFR) is translocated into the nucleus, which increases cancer cell activity. Nicotine, which is one of the main components of tobacco, is absorbed through pulmonary alveoli and mucosal epithelia in the head and neck region by smoking and moves into the blood. Nicotine in blood binds to nicotinic acetylcholine receptor (nAChR) in the central nervous system and serves a crucial role in tobacco addiction. Although nAChR localization is thought to be limited in the nervous system, nAChR is present in a wide variety of non‑neuronal cells, including cancer cells. Recent studies suggest that nicotine contributes to the metastasis and resistance to anti‑cancer drugs of various cancer cells. However, it remains unknown whether head and neck squamous cell carcinoma (HNSCC) cells can utilize nicotine‑nAChR signaling to metastasize and acquire resistance to anti‑cancer drugs, even though the mucosal epithelia of the head and neck region are the primary sites of exposure to tobacco smoke. To the best of our knowledge, the present study is the first to demonstrate the role of nicotine in metastasis and anti‑EGFR‑therapy resistance of HNSCC. The present findings demonstrated that nicotine increased proliferation, migration, invasion, p‑EGFR nuclear translocation and protein kinase B (Akt) phosphorylation in HNSCC cells. It was also demonstrated that nicotine restored cetuximab‑inhibited proliferation, migration and invasion of HNSCC cells. Finally, an in vivo experiment revealed that nicotine increased lymph node metastasis of xenografted tumors, whereas an nAChR inhibitor suppressed lymph node metastasis and p‑EGFR nuclear localization of xenografted tumors. Taken together, these results demonstrated that nicotine induced nuclear accumulation of p‑EGFR, and activation of Akt signaling. These signaling pathways elevated the activities of HNSCC cells, causing lymph node metastasis and serving a role in cetuximab resistance.

    DOI: 10.3892/ijo.2018.4631

    PubMed

    researchmap

  • 脂質・コレステロール排出ポンプABCG1標的による腫瘍内エクソソーム蓄積および腫瘍縮小

    江口 傑徳, 十川 千春, 難波 友里, 奥舎 有加, 河合 穂高, 小野 喜章, 板垣 まみ, 村上 純, 大山 和美, 浅海 淳一, 岡元 邦彰

    日本薬理学会年会要旨集   92   2-YIA-26   2019年

     詳細を見る

    記述言語:日本語   出版者・発行元:公益社団法人 日本薬理学会  

    The ATP-binding cassette transporter G1 (ABCG1) is a cholesterol lipid efflux pump whose role in tumor growth has been largely unknown. Our transcriptomics revealed that ABCG1 was powerfully expressed in rapidly metastatic, aggregative colon cancer cells, in all the ABC transporter family members. Coincidently, genetic amplification of ABCG1 is found in 10% to 35% of clinical samples of metastatic cancer cases. Expression of ABCG1 was further elevated in three-dimensional tumoroids (tumor organoids) within stemness-enhancing tumor milieu, whereas depletion of ABCG1 lowered cellular aggregation and tumoroid growth in vitro as well as hypoxia-inducible factor 1α in cancer cells around the central necrotic areas in tumors in vivo. Notably, depletion of ABCG1 triggered the intracellular accumulation of extracellular vesicles (EVs) and regression of tumoroids. Collectively, these data suggest that ABCG1 plays a crucial role in tumorigenesis in metastatic cancer and that depletion of ABCG1 triggers tumor regression with the accumulation of EVs, their derivatives and cargos, implicating a novel ABCG1-targeting therapeutic strategy by which redundant and toxic substances may be accumulated in tumors leading to their regression.

    DOI: 10.1254/jpssuppl.92.0_2-yia-26

    CiNii Article

    researchmap

  • MMP9プロモーター活性を指標とした三次元培養システムを用いた抗がん剤スクリーニングによる薬剤再開発

    十川 千春, 江口 傑徳, 奥舎 有加, 大山 和美, 小野 喜章, 十川 紀夫, 岡元 邦彰

    日本薬理学会年会要旨集   92   1-P-096   2019年

     詳細を見る

    記述言語:日本語   出版者・発行元:公益社団法人 日本薬理学会  

    Cancer is one of the most serious diseases all over the world, especially metastasis and drug resistance are leading causes of death. There is an urgent need to establish new strategies for drug discovery. Success in the drug discovery depends on the development of appropriate tumor models that correspond closely to native tumor situation. Matrix metalloproteinases (MMPs) represent the most prominent family of proteinases associated with tumorigenesis and are regulators of tumor milieu. The cancer stem cell model fits well with tumorigenesis, metastasis and drug resistance. We have shown that cancer cell aggregation led to hypoxic tumoroids with marked upregulation of reprogramming and stemness genes as increased cancer stem cell using a 3D culture system. In the present study, we established a novel MMP9 promoter-driven cell-based reporter system using a rapidly metastatic colon cancer cell in the 3D culture system that evaluates cancer stemness and invasiveness. We used a concept of drug repositioning-using known molecules for new indications. We selected several compounds with inhibition to both tumoroid formation and MMP9 promoter activity. One of the compounds inhibited primary tumor formation, invasion and metastasis.

    DOI: 10.1254/jpssuppl.92.0_1-p-096

    CiNii Article

    researchmap

  • Regulatory Roles of HSP90-Rich Extracellular Vesicles

    Takanori Eguchi, Kisho Ono, Kazumi Kawata, Kuniaki Okamoto, Stuart K. Calderwood

    Heat Shock Proteins   3 - 17   2019年

     詳細を見る

    掲載種別:論文集(書籍)内論文   出版者・発行元:Springer International Publishing  

    DOI: 10.1007/978-3-030-23158-3_1

    researchmap

  • Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab. 査読 国際誌

    Toshifumi Fujiwara, Takanori Eguchi, Chiharu Sogawa, Kisho Ono, Jun Murakami, Soichiro Ibaragi, Jun-Ichi Asaumi, Stuart K Calderwood, Kuniaki Okamoto, Ken-Ichi Kozaki

    Oral oncology   86   251 - 257   2018年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Overexpression and increased signaling from the epidermal growth factor receptor (EGFR) often changes oral squamous cell carcinoma (OSCC) and thus EGFR is frequently targeted molecularly by the therapeutic antibody cetuximab. We assessed the roles of OSCC-derived extracellular vesicles (EVs), including exosomes in the trafficking of cetuximab and in epithelial-mesenchymal transition (EMT) of epithelial cells. OSCC cells abundantly expressed EGFR, which was secreted from cells with OSCC-EVs upon EGF stimulations. The OSCC-EGFR-EVs were then able to enter into and transform epithelial cells leading to increased mesenchymal traits with increased vimentin and spindle-like shapes. EGF priming of OSCC cells further increased this EMT-initiating effect of the OSCC-EVs. The internalization and pro-EMT effects of the OSCC-EVs were largely blocked by cetuximab. Thus, OSCC-derived EVs transform normal epithelial cells into a mesenchymal phenotype and anti-EGFR therapeutic antibody cetuximab inhibits such a carcinogenic effect of the OSCC-EVs.

    DOI: 10.1016/j.oraloncology.2018.09.030

    PubMed

    researchmap

  • Lipoprotein Cholesterols Are Stored in High-Resistant, Metastatic Cancer Cells and Released Upon Stress: Implication for a Mechanism Underlying Hypocholesterolemia in Cancer Patients

    Taka Eguchi, Chiharu Sogawa, Kisho Ono, Mami Itagaki, Masaki Matsumoto

    2018年10月

     詳細を見る

    出版者・発行元:MDPI AG  

    Resistant cancer often shows a particular secretory trait such as heat shock proteins (HSPs) and extracellular vesicles (EVs), including exosomes and oncosomes surrounded by lipid bilayers. Lipoproteins are biochemical assemblies that transport hydrophobic lipid (a.k.a. fat) molecules in body fluid and are composed of a single-layer phospholipid and cholesterol outer shell, lipids molecules within the particles, and apolipoproteins embedded in the membrane. However, lipoprotein storage and secretion by cancer cells have not well-investigated yet. We found lipoproteins were stored and abundantly secreted by neuroendocrine, castration-resistant prostate cancer (NEPC / CRPC) cells but barely secreted by colon cancer cells and oral squamous cell carcinoma (OSCC) cells. In addition, large EVs (approx. 300 nm diameter) and potential oncosomes were released by CRPC and OSCC cells. Proteomics revealed that CRPC cells secreted EVs enriched with tetraspanins and extracellular matrices which were reduced upon heat shock stress and alternatively lipoproteins and HSPs were secreted upon stress. Heat shock stress triggered secretion of lipoprotein-EV complexes that contained apolipoprotein A, B, C and E. These data suggested that vesicular assembly composed of EVs and lipoproteins enriched with cholesterols and phospholipids may be stored in resistant cancer cells but released upon cell stress that is increased in cancer therapies.

    DOI: 10.20944/preprints201810.0211.v1

    researchmap

  • Anti-EGFR antibody cetuximab is secreted by oral squamous cell carcinoma and alters EGF-driven mesenchymal transition. 査読 国際誌

    Toshifumi Fujiwara, Takanori Eguchi, Chiharu Sogawa, Kisho Ono, Jun Murakami, Soichiro Ibaragi, Jun-Ichi Asaumi, Kuniaki Okamoto, Stuart K Calderwood, Ken-Ichi Kozaki

    Biochemical and biophysical research communications   503 ( 3 )   1267 - 1272   2018年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Genetic amplification, overexpression, and increased signaling from the epidermal growth factor receptor (EGFR) are often found in oral squamous cell carcinoma (OSCC) and thus EGFR is frequently targeted molecularly by the therapeutic antibody cetuximab. We assessed effects of cetuximab in control of EGF-driven malignant traits of OSCC cells. EGF stimulation promoted progression level of mesenchymal traits in OSCC cells, which were attenuated by cetuximab but incompletely. We pursued a potential mechanism underlying such incomplete attenuation of OSCC malignant traits. Cetuximab promoted secretion of EGFR-EVs by OSCC cells and failed to inhibit EGF-driven secretion of EGFR-EVs. Cetuximab was also found to be robustly secreted with the EGFR-EVs by the OSCC cells. Thus, EGF promotes the level of mesenchymal traits of OSCC cells and secretion of EGFR-EVs, which involve cetuximab resistance.

    DOI: 10.1016/j.bbrc.2018.07.035

    PubMed

    researchmap

  • HSP-enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells. 査読 国際誌

    Kisho Ono, Takanori Eguchi, Chiharu Sogawa, Stuart K Calderwood, Junya Futagawa, Tomonari Kasai, Masaharu Seno, Kuniaki Okamoto, Akira Sasaki, Ken-Ichi Kozaki

    Journal of cellular biochemistry   119 ( 9 )   7350 - 7362   2018年9月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Cancer cells often secrete extracellular vesicles (EVs) that carry heat shock proteins (HSPs) with roles in tumor progression. Oral squamous cell carcinoma (OSCC) belongs to head and neck cancers (HNC) whose lymph-node-metastases often lead to poor prognosis. We have examined the EV proteome of OSCC cells and found abundant secretion of HSP90-enriched EVs in lymph-node-metastatic OSCC cells. Double knockdown of HSP90α and HSP90β, using small interfering RNA significantly reduced the survival of the metastatic OSCC cells, although single knockdown of each HSP90 was ineffective. Elevated expression of these HSP90 family members was found to correlate with poor prognosis of HNC cases. Thus, elevated HSP90 levels in secreted vesicles are potential prognostic biomarkers and therapeutic targets in metastatic OSCC.

    DOI: 10.1002/jcb.27039

    PubMed

    researchmap

  • がん幹細胞特性をもつオルガノイドによるEPCAMエクソソームおよびHSP90の分泌(Organoids with Cancer Stem Cell-like Properties Secrete EpCAM-Exosomes and HSP90 in a 3D NanoEnvironment) 査読 国際誌

    十川 千春, 江口 傑徳, 小野 喜章, 奥舎 有加, 中面 哲也, Calderwood Stuart K., 小崎 健一

    日本癌学会総会記事   77回 ( 2 )   2332 - 2332   2018年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    Ability to form cellular aggregations such as tumorspheres and spheroids have been used as a morphological marker of malignant cancer cells and in particular cancer stem cells (CSC). However, the common definition of the types of cellular aggregation formed by cancer cells has not been available. We examined morphologies of 67 cell lines cultured on three dimensional morphology enhancing NanoCulture Plates (NCP) and classified the types of cellular aggregates that form. Among the 67 cell lines, 49 cell lines formed spheres or spheroids, 8 cell lines formed grape-like aggregation (GLA), 8 cell lines formed other types of aggregation, and 3 cell lines formed monolayer sheets. Seven GLA-forming cell lines were derived from adenocarcinoma among the 8 lines. A neuroendocrine adenocarcinoma cell line PC-3 formed asymmetric GLA with ductal structures on the NCPs and rapidly growing asymmetric tumors that metastasized to lymph nodes in immunocompromised mice. In contrast, another adenocarcinoma cell line DU-145 formed spheroids in vitro and spheroid-like tumors in vivo that did not metastasize to lymph nodes until day 50 after transplantation. Culture in the 3D nanoenvironment and in a defined stem cell medium enabled the neuroendocrine adenocarcinoma cells to form slowly growing large organoids that expressed multiple stem cell markers, neuroendocrine markers, intercellular adhesion molecules, and oncogenes in vitro. In contrast, the more commonly used 2D serum-contained environment reduced intercellular adhesion and induced mesenchymal transition and promoted rapid growth of the cells. In addition, the 3D stemness nanoenvironment promoted secretion of HSP90 and EpCAM-exosomes, a marker of CSC phenotype, from the neuroendocrine organoids. These findings indicate that the NCP-based 3D environment enables cells to form stem cell tumoroids with multipotency and model more accurately the in vivo tumor status at the levels of morphology and gene expression.

    DOI: 10.1371/journal.pone.0191109

    PubMed

    researchmap

  • Depletion of Lipid Efflux Pump ABCG1 Triggers the Intracellular Accumulation of Extracellular Vesicles and Reduces Aggregation and Tumorigenesis of Metastatic Cancer Cells. 査読 国際誌

    Yuri Namba, Chiharu Sogawa, Yuka Okusha, Hotaka Kawai, Mami Itagaki, Kisho Ono, Jun Murakami, Eriko Aoyama, Kazumi Ohyama, Jun-Ichi Asaumi, Masaharu Takigawa, Kuniaki Okamoto, Stuart K Calderwood, Ken-Ichi Kozaki, Takanori Eguchi

    Frontiers in oncology   8   376 - 376   2018年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The ATP-binding cassette transporter G1 (ABCG1) is a cholesterol lipid efflux pump whose role in tumor growth has been largely unknown. Our transcriptomics revealed that ABCG1 was powerfully expressed in rapidly metastatic, aggregative colon cancer cells, in all the ABC transporter family members. Coincidently, genetic amplification of ABCG1 is found in 10-35% of clinical samples of metastatic cancer cases. Expression of ABCG1 was further elevated in three-dimensional tumoroids (tumor organoids) within stemness-enhancing tumor milieu, whereas depletion of ABCG1 lowered cellular aggregation and tumoroid growth in vitro as well as hypoxia-inducible factor 1α in cancer cells around the central necrotic areas in tumors in vivo. Notably, depletion of ABCG1 triggered the intracellular accumulation of extracellular vesicles (EVs) and regression of tumoroids. Collectively, these data suggest that ABCG1 plays a crucial role in tumorigenesis in metastatic cancer and that depletion of ABCG1 triggers tumor regression with the accumulation of EVs and their derivatives and cargos, implicating a novel ABCG1-targeting therapeutic strategy by which redundant and toxic substances may be accumulated in tumors leading to their regression.

    DOI: 10.3389/fonc.2018.00376

    PubMed

    researchmap

▼全件表示

書籍等出版物

  • Extraction of the Mandibular Third Molar: An Evidence-based Guide

    Springer  2025年5月  ( ISBN:3031854659

     詳細を見る

    総ページ数:323  

    ASIN

    researchmap

  • BIO Clinica (2024年7月号) 抗体医薬の現状と展望

    小野 喜章, 河合穂高, 長塚 仁, 伊原木聰一郎( 範囲: BIOLOGY TOPICS「セツキシマブ抵抗性口腔癌への基礎研究戦略」p42-47)

    株式会社 ニューサイエンス社  2024年7月 

     詳細を見る

  • Multiplex immunostaining method to distinguish HSP isoforms. In: Methods Molecular Biology, Vol.2693, Stuart K. Calderwood and Thomas L. Prince (Eds): Chaperones.

    Hotaka Kawai, Kisho Ono, Takanori Eguchi( 範囲: pp.281-291)

    Springer Nature Switzerland AG, Cham, Switzerland.  2023年8月 

     詳細を見る

  • Multiple targeting of HSP isoforms to challenge isoform specificity and compensatory expression. In: Methods Molecular Biology, Vol.2693 , Stuart K. Calderwood and Thomas L. Prince (Eds): Chaperones.

    Kisho Ono, Takanori Eguchi( 範囲: pp.141-161)

    Springer Nature Switzerland AG, Cham, Switzerland.  2023年8月 

     詳細を見る

  • Proteomic profiling of the extracellular vesicle-chaperome in cancer. In: Methods Molecular Biology, Vol.2693 , Stuart K. Calderwood and Thomas L. Prince (Eds): Chaperones.

    Kisho Ono, Takanori Eguchi( 範囲: pp.233-249)

    Springer Nature Switzerland AG, Cham, Switzerland.  2023年8月 

     詳細を見る

  • Large-scale databases and portals on cancer genome to analyze chaperone genes correlated to patient prognosis. In: Methods Molecular Biology, Vol.2693 , Stuart K. Calderwood and Thomas L. Prince (Eds): Chaperones.

    Kisho Ono, Takanori Eguchi( 範囲: pp.293-306)

    Springer Nature Switzerland AG, Cham, Switzerland.  2023年8月 

     詳細を見る

  • Western Blot Protocols for Analysis of CCN Proteins and Fragments in Exosomes, Vesicle-free Fractions, and Cells. In: Masaharu Takigawa (eds) CCN Proteins. Methods in Molecular Biology, vol 2582.

    Kisho Ono, Yuka Okusha, Manh Tien Tran, Koki Umemori, Takanori Eguchi( 範囲: pp.39-57)

    Humana, New York, NY.  2022年12月 

     詳細を見る

  • Comprehensive Method for Exosome Isolation and Proteome Analysis for Detection of CCN Factors in/on Exosomes. In: Masaharu Takigawa (eds) CCN Proteins. Methods in Molecular Biology, vol 2582.

    Takanori Eguchi, Yuka Okusha, Yanyin Lu, Kisho Ono, Eman A. Taha, Shiro Fukuoka( 範囲: pp.59-76)

    Humana, New York, NY.  2022年12月 

     詳細を見る

  • Regulatory roles of HSP90-rich extracellular vesicles. Heat Shock Protein 90 in Human Diseases and Disorders. Heat Shock Proteins Book Series, vol. 19

    Eguchi T, Ono K, Kawata K, Okamoto K, Calderwood SK( 担当: 共著)

    Springer Nature  2019年 

     詳細を見る

▼全件表示

MISC

  • 口腔内細菌に起因したと考えられる腰部筋肉内膿瘍の1例

    梅森洸樹, 小畑協一, 小畑協一, 矢尾真弓, 矢尾真弓, 竜門省二, 竜門省二, 小川辰雄, 吉田国弘, 金本栄華, 小野喜章, 國定勇希, 伊原木聰一郎, 伊原木聰一郎

    日本口腔科学会学術集会プログラム・抄録集   78th   2024年

     詳細を見る

  • 舌下面に発生した神経鞘腫の1例

    福嶋輝保, 小野喜章, 山本和泉, 小畑協一, 國定勇希, 柚鳥宏和, 伊原木聰一郎

    日本口腔科学会雑誌(Web)   72 ( 4 )   2023年

     詳細を見る

  • 口腔外科受診を契機に診断・治療に至った舌咽神経痛の1例

    木村拓紀, 小野喜章, 福嶋輝保, 小畑協一, 國定勇希, 伊原木聰一郎

    日本口腔科学会雑誌(Web)   72 ( 4 )   2023年

     詳細を見る

  • 上顎前歯部歯肉に発生した周辺性石灰化歯原性嚢胞の1例

    山本和泉, 小畑協一, 小畑協一, 矢尾真弓, 福嶋輝保, 小野喜章, 國定勇希, 伊原木聰一郎

    日本口腔科学会雑誌(Web)   72 ( 4 )   2023年

     詳細を見る

  • 救急集中治療室での集学的全身管理を要した歯性感染症の臨床統計的検討

    山本和泉, 小野喜章, 小畑協一, 竜門省二, 村瀬友里香, 柚鳥宏和, 吉岡徳枝, 伊原木聰一郎

    日本口腔科学会学術集会プログラム・抄録集   77th   2023年

     詳細を見る

  • 頭頸部癌におけるセツキシマブ感受性予測バイオマーカーとしてのEpCAMの可能性

    小野喜章, 梅森洸樹, 中村友哉, 小川辰雄, 金本栄華, 吉田国弘, 小畑協一, 竜門省二, 柚鳥宏和, 河合穂高, 片瀬直樹, 奥井達雄, 長塚仁, 伊原木聰一郎

    日本口腔腫瘍学会総会・学術大会プログラム・抄録集   41st   2023年

     詳細を見る

  • 肺に併発した上顎歯肉Epstein-Barr virus-positive mucocutaneous ulcerの一例

    小畑協一, 柚鳥宏和, 吉田国弘, 小野喜章, 吉岡徳枝, 西山明慶, 伊原木聡一郎

    日本口腔腫瘍学会総会・学術大会プログラム・抄録集   41st   2023年

     詳細を見る

  • 気管切開術~口腔腫瘍治療医の登竜門的手術~

    柚鳥宏和, 伊原木聰一郎, 小畑協一, 増井正典, 小野喜章, 吉岡徳枝, 西山明慶, 佐々木朗

    日本口腔腫瘍学会総会・学術大会プログラム・抄録集   40th   2022年

     詳細を見る

  • 侵襲性歯周炎の血液診断マーカー候補となる細胞外小胞由来マイクロRNAとその炎症誘導機構の探索

    森彩乃, 山本直史, 井手口英隆, 河村麻理, 河本美奈, 伊東昌洋, 小野喜章, 中山真彰, 江口傑徳, 大野充昭, 大森一弘, 高柴正悟

    日本歯周病学会会誌(Web)   64   2022年

     詳細を見る

  • 顎骨壊死を伴ったEBV陽性皮膚粘膜潰瘍(EBV-MCU)の2例

    竜門 省二, 岸本 晃治, 奥井 達雄, 吉岡 徳枝, 小畑 協一, 國定 勇希, 増井 正典, 小野 喜章, 伊原木 聰一郎, 佐々木 朗

    日本口腔診断学会雑誌   34 ( 1 )   71 - 71   2021年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔診断学会  

    researchmap

  • 顎骨壊死を伴ったEBV陽性皮膚粘膜潰瘍(EBV-MCU)の2例

    竜門 省二, 岸本 晃治, 奥井 達雄, 吉岡 徳枝, 小畑 協一, 國定 勇希, 増井 正典, 小野 喜章, 伊原木 聰一郎, 佐々木 朗

    日本口腔内科学会雑誌   26 ( 2 )   119 - 119   2020年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • 侵襲性歯周炎の血液診断バイオマーカーとしての細胞外小胞由来マイクロRNAの探索

    河本 美奈, 山本 直史, 河村 麻理, 森 彩乃, 山城 圭介, 大森 一弘, 小野 喜章, 江口 傑徳, 十川 千春, 高柴 正悟

    岡山歯学会雑誌   39 ( 2 )   35 - 36   2020年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:岡山歯学会  

    researchmap

  • ニコチンが口腔癌細胞に与える影響の検討

    伊原木 聰一郎, 清水 理恵子, 奥井 達雄, 高畠 清文, 河合 穂高, 小野 喜章, 長塚 仁, 佐々木 朗

    日本口腔科学会雑誌   69 ( 3 )   235 - 235   2020年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本口腔科学会  

    researchmap

  • 下顎枝から翼突下顎隙に大きく膨隆した含歯性嚢胞の1例

    西山 明慶, 伊原木 聰一郎, 奥井 達雄, 小野 喜章, 佐々木 朗

    日本口腔科学会雑誌   69 ( 3 )   240 - 240   2020年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本口腔科学会  

    researchmap

  • ニコチンが口腔癌細胞に与える影響の検討

    伊原木聰一郎, 清水理恵子, 奥井達雄, 高畠清文, 河合穂高, 小野喜章, 長塚仁, 佐々木朗

    日本口腔科学会雑誌(Web)   69 ( 3 )   2020年

     詳細を見る

  • 生検によって自然治癒した小児の下顎に生じたLangerhans細胞組織球症の1例

    小野 喜章, 佐々木 朗

    小児口腔外科   29 ( 2 )   214 - 214   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本小児口腔外科学会  

    researchmap

  • 下顎前歯部に発生した骨形成性エプーリスの1例

    廣瀬 泰良, 伊原木 聰一郎, 小野 喜章, 佐々木 朗

    日本口腔診断学会雑誌   32 ( 1 )   107 - 107   2019年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔診断学会  

    researchmap

  • 分子シャペロントリオによるエクソソーム制御,腫瘍悪性化およびマクロファージ分極について

    江口傑徳, 小野喜章, 小野喜章, 河合穂高, チャン チェンマン, 十川千春, 奥舎有加, 岡元邦彰

    日本臨床ストレス応答学会大会抄録集   14th   2019年

     詳細を見る

  • ニコチンは口腔扁平上皮癌細胞のセツキシマブ耐性を促進する

    清水 理恵子, 伊原木 聰一郎, 江口 傑徳, 奥井 達雄, 高畠 清文, 河合 穂高, 小野 喜章, 岡元 邦彰, 長塚 仁, 佐々木 朗

    岡山歯学会雑誌   37 ( 2 )   80 - 81   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:岡山歯学会  

    researchmap

  • 下顎前歯部に発生した骨形成性エプーリスの1例

    廣瀬 泰良, 伊原木 聰一郎, 小野 喜章, 佐々木 朗

    日本口腔内科学会雑誌   24 ( 2 )   95 - 95   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本口腔内科学会  

    researchmap

  • 大腸癌の増殖,浸潤,転移を促進するPEXドメインの役割とその制御(The intranuclear PEX domain of MMP involves proliferation, migration, and metastasis of aggressive adenocarcinoma cells)

    江口 傑徳, 奥舎 有加, 小野 喜章, 十川 千春, Calderwood Stuart K., 小崎 健一

    日本癌学会総会記事   77回   1332 - 1332   2018年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 癌の治療抵抗性と転移におけるHSP90およびMMP3の役割

    江口 傑徳, 小野 喜章, 奥舎 有加, 十川 千春, 内部 健太, 中野 敬介, 奥井 達雄, 滝川 正春, 岡元 邦彰, カルダーウッド・スチュアート

    Journal of Oral Biosciences Supplement   2018   142 - 142   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)歯科基礎医学会  

    researchmap

  • 核内およびエクソソーム中に存在するMMPs/PEXの癌進展における役割とその抑制

    奥舎 有加, 江口 傑徳, 十川 千春, 小野 喜章, 奥井 達雄, 中野 敬介, 岡元 邦彰

    Journal of Oral Biosciences Supplement   2018   150 - 150   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)歯科基礎医学会  

    researchmap

  • 急速転移性癌細胞株由来細胞外小胞による破骨細胞分化および癌細胞浸潤の制御

    板垣 まみ, 十川 千春, 奥舎 有加, 江口 傑徳, 小野 喜章, 岡元 邦彰

    Journal of Oral Biosciences Supplement   2018   347 - 347   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)歯科基礎医学会  

    researchmap

  • エクソソーム研究の「がん」における新展開 細胞外小胞のHSPに富む特性は、転移性口腔癌細胞の生存を担う(HSP-enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells)

    小野 喜章, 江口 傑徳, 十川 千春, 佐々木 朗

    日本癌学会総会記事   77回   897 - 897   2018年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 知覚神経の興奮は骨内での乳がん進展に寄与する

    奥井 達雄, 小野 喜章, 佐々木 朗

    Journal of Oral Biosciences Supplement   2018   201 - 201   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)歯科基礎医学会  

    researchmap

  • 口腔扁平上皮癌診断・治療における分子シャペロンHSP90含有細胞外小胞の可能性

    小野 喜章, 江口 傑徳, 十川 千春, 奥舎 有加, 河合 穂高, 中野 敬介, 佐々木 朗, 岡元 邦彰, 小崎 健一

    Journal of Oral Biosciences Supplement   2018   333 - 333   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)歯科基礎医学会  

    researchmap

  • 口腔扁平上皮癌細胞株が分泌するエクソソーム中に見つかった腫瘍進展・転移因子

    小野喜章, 江口傑徳, 佐々木朗

    日本口腔腫瘍学会総会・学術大会プログラム・抄録集   36th   2018年

     詳細を見る

  • 癌の治療抵抗性と転移におけるHSP90およびMMP3の役割

    江口傑徳, 江口傑徳, 小野喜章, 小野喜章, 奥舎有加, 十川千春, 内部健太, 中野敬介, 中野敬介, 奥井達雄, 滝川正春, 岡元邦彰, CALDERWOOD SK

    Journal of Oral Biosciences Supplement (Web)   2018   2018年

     詳細を見る

  • Tumoroid Never Knows?腫瘍オルガノイドと細胞外小胞からみる難治性がん研究・治療のミライ

    江口傑徳, 小野喜章, 奥舎有加, 藤原敏史, 十川千春, CALDERWOOD Stuart

    日本分子生物学会年会プログラム・要旨集(Web)   41st   2018年

     詳細を見る

  • 核内およびエクソソーム中に存在するMMPs/PEXの癌進展における役割とその抑制

    奥舎有加, 江口傑徳, 江口傑徳, 十川千春, 小野喜章, 小野喜章, 奥井達雄, 中野敬介, 岡元邦彰

    Journal of Oral Biosciences Supplement (Web)   2018   2018年

     詳細を見る

  • 急速転移性癌細胞株由来細胞外小胞による破骨細胞分化および癌細胞浸潤の制御

    板垣まみ, 十川千春, 奥舎有加, 江口傑徳, 江口傑徳, 小野喜章, 岡元邦彰

    Journal of Oral Biosciences Supplement (Web)   2018   2018年

     詳細を見る

  • 口腔扁平上皮癌診断・治療における分子シャペロンHSP90含有細胞外小胞の可能性

    小野喜章, 江口傑徳, 江口傑徳, 十川千春, 奥舎有加, 河合穂高, 中野敬介, 佐々木朗, 岡元邦彰, 小崎健一

    Journal of Oral Biosciences Supplement (Web)   2018   2018年

     詳細を見る

  • 異なる転移能を有する口腔扁平上皮癌細胞由来エクソソームに含まれるプロテオームの特性

    小野 喜章, 江口 傑徳, 十川 千春, 村上 純, 藤原 敏史, 笠井 智成, 妹尾 昌治, 佐々木 朗, 小崎 健一, 岡元 邦彰

    生命科学系学会合同年次大会   2017年度   [1LBA - 052]   2017年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:生命科学系学会合同年次大会運営事務局  

    researchmap

  • 舌癌細胞株由来エクソソーム解析による頸部リンパ節転移マーカーの探索

    小野 喜章, 江口 傑徳, 十川 千春, 村上 純, 笠井 智成, 妹尾 昌治, 佐々木 朗, 小崎 健一

    日本癌学会総会記事   76回   J - 1062   2017年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 口腔扁平上皮癌細胞由来エクソソームに含まれる分子シャペロンについての検討

    小野喜章, 小野喜章, 江口傑徳, 十川千春, 村上純, 藤原敏史, 藤原敏史, 笠井智成, 妹尾昌治, 佐々木朗, 小崎健一, 岡元邦彰

    臨床ストレス応答学会大会抄録集   12th   2017年

     詳細を見る

  • 口腔扁平上皮癌における術前化学療法に伴う腫瘍浸潤リンパ球の変化

    高倉 裕明, 銅前 昇平, 國定 勇希, 吉田 祥子, 小野 喜章, 岸本 晃治, 佐々木 朗

    頭頸部癌   42 ( 2 )   221 - 221   2016年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本頭頸部癌学会  

    researchmap

  • 腫瘍微小環境シグナルによる上皮間葉転換およびエクソソーム変化についての解析

    藤原敏史, 十川千春, 小野喜章, 村上純, 浅海淳一, 小崎健一, 江口傑徳

    日本分子生物学会年会プログラム・要旨集(Web)   39th   2016年

     詳細を見る

▼全件表示

講演・口頭発表等

  • EPCAM–CD9 axis integrates tumor cell state and extracellular vesicle–mediated resistance to anti-EGFR therapy in head and neck squamous cell carcinoma

    Kisho Ono, Koki Umemori, Kohei Sato, Hotaka Kawai, Nana Yoshitani, Hiroaki Takakura, Kyoichi Obata, Yuki Kunisada, Tatsuo Okui, Hitoshi Nagatsuka, Fatemeh Momen-Heravi, Soichiro Ibaragi

    The 9th JCA-AACR Special Joint Conference Novel Therapies and Diagnostics in Upper Digestive and Head and Neck Cancers  2026年6月29日 

     詳細を見る

    開催年月日: 2026年6月28日 - 2026年6月30日

    記述言語:英語   会議種別:ポスター発表  

    researchmap

  • EPCAM-CD9軸が規定する頭頸部扁平上皮癌の抗EGFR治療耐性機構

    小野喜章, 高倉裕明, 小畑協一, 國定勇希, 伊原木聰一郎

    第50回日本頭頸部癌学会総会・学術講演会  2026年6月12日 

     詳細を見る

    開催年月日: 2026年6月11日 - 2026年6月12日

    記述言語:英語   会議種別:ポスター発表  

    researchmap

  • Caspase-8 as Extracellular Vesicle-cargo Regulator in Head and Neck Cancer

    Kisho Ono, Sahib Zada, Jarvan Jiang, Fatemeh Momen-Heravi

    2025 AADOCR/IADR Annual Meeting & Exhibition  2025年3月13日 

     詳細を見る

    開催年月日: 2025年3月12日 - 2025年3月15日

    記述言語:英語  

    researchmap

  • 国際口腔顎顔面外科専門医試験を受けて 招待

    小野喜章

    若手口腔外科医交流会第2回学術集会  2024年5月11日 

     詳細を見る

    開催年月日: 2024年5月11日 - 2024年5月12日

    記述言語:日本語   会議種別:シンポジウム・ワークショップ パネル(指名)  

    researchmap

  • Elucidating the Role of Double Negative T Cells in the Pathogenesis of Oral Inflammation

    Yi-Chu Wu, Kisho Ono, Kranthi Tanagala, Sunil Dubey, Hemant Gujar, Michael Kissner, Fatemeh Momen-Heravi

    2024年 

     詳細を見る

    開催年月日: 2024年

    researchmap

  • 次世代口腔外科医の国際化を目指した国際口腔顎顔面外科専門医への挑戦 招待

    小野喜章, 吉岡徳枝, 伊原木 聰一郎

    第1回若手口腔外科医交流会  2023年7月29日 

     詳細を見る

    開催年月日: 2023年7月29日 - 2023年7月30日

    記述言語:日本語   会議種別:シンポジウム・ワークショップ パネル(指名)  

    researchmap

  • 上顎のカントを伴う非対称に対して非偏位側を Trauner-Obwegeser法に準じて骨切りした2例

    小野喜章, 吉岡德枝, 小畑協一, 坂本裕美, 西山明慶, 伊原木聰一郎

    第33回 日本顎変形症学会総会・学術大会  2023年6月8日 

     詳細を見る

    開催年月日: 2023年6月8日 - 2023年6月9日

    researchmap

  • 口腔癌の細胞外小胞と銅輸送経路に着目したシスプラチン耐性機構の解明と克服のための挑戦的研究

    小野喜章, 竜門省二, 小畑協一, 河合穂高, 奥井達雄, 伊原木聰一郎

    第77回NPO法人日本口腔科学会学術集会  2023年5月 

     詳細を見る

    開催年月日: 2023年5月11日 - 2023年5月13日

    researchmap

  • 頭頸部癌におけるセツキシマブ感受性予測バイオマーカーとしてのEpCAMの可能性

    小野喜章, 梅森洸樹, 中村友哉, 小川辰雄, 金本栄華, 吉田国弘, 小畑協一, 竜門省二, 柚鳥宏和, 河合穂高, 片瀬直樹, 奥井達雄, 長塚仁, 伊原木聰一郎

    第41回日本口腔腫瘍学会総会・学術大会  2023年1月 

     詳細を見る

    開催年月日: 2023年1月26日 - 2023年2月28日

    researchmap

  • 細胞外小胞と銅輸送経路に着目した口腔癌のシスプラチン耐性機構の解明

    小野 喜章, 竜門 省二, 金本 栄華, 梅森 洸樹, 坂本 裕美, 小畑 協一, 吉岡 徳枝, 伊原木 聰一郎, 佐々木 朗

    第32回日本口腔内科学会  2022年9月 

     詳細を見る

    開催年月日: 2022年9月

    researchmap

  • 頭頸部扁平上皮癌における EpCAM誘導性セツキシマブ耐性獲得機構の解明

    小野喜章, 小畑協一, 増井正典, 吉岡德枝, 伊原木聰一郎, 佐々木 朗

    第46回日本頭頸部癌学会  2022年6月 

     詳細を見る

    開催年月日: 2022年6月

    researchmap

  • 口腔癌の薬剤応答性に対する3次元培養モデル有用性の検証

    佐藤晃平, 小野喜章, 吉田夢, 中村友哉, 梅森洸樹, 金本栄華, 吉田国弘, 小畑協一, 伊原木, 聰一郎, 佐々木 朗

    第57回口腔組織培養学会  2021年11月6日 

     詳細を見る

    開催年月日: 2021年11月6日

    会議種別:口頭発表(一般)  

    researchmap

  • 口腔癌のエクソソームを介した腫瘍進展機序の解明と新規治療戦略の開発に向けて〜分子シャペロン搭載エクソソームの可能性〜

    小野喜章, 江口傑徳, 十川千春, 奥舎有加, 岡元邦彰, 佐々木朗

    第57回口腔組織培養学会  2021年11月6日 

     詳細を見る

    開催年月日: 2021年11月6日

    会議種別:口頭発表(一般)  

    researchmap

  • 口腔顎顔面外科解剖研究会の設立:口腔外科と解剖の接点が持つ意義と将来への展望

    岩永 譲, 松下 祐樹, 拝形 祐登, 小野 喜章, 増井 正典, 喜久田 翔伍, 竹下 洋平, 奥井 達雄, 影山 幾男, 伊原木 聰一郎

    第66回日本口腔外科学会総会・学術大会  2021年11月 

     詳細を見る

    開催年月日: 2021年11月

    記述言語:日本語  

    researchmap

  • 下顎骨の骨吸収抑制薬関連顎骨壊死に対しカスタムメイドプレートで再建を行った症例

    小畑 協一, 伊原木 聰一郎, 柚鳥 宏和, 金本 栄華, 梅森 洸樹, 小野 喜章, 増井 正典, 佐々木 朗

    第66回日本口腔外科学会総会・学術大会  2021年11月 

     詳細を見る

    開催年月日: 2021年11月

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 関節頭付きプレートとメッシュトレーを併用してPCBM移植により下顎を再建した1例

    吉岡 徳枝, 伊原木 聰一郎, 小野 喜章, 小畑 協一, 佐々木 朗

    第66回日本口腔外科学会総会・学術大会  2021年11月 

     詳細を見る

    開催年月日: 2021年11月

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 3 次元培養システムを用いた口腔癌の薬剤応答性に対する新規in vitroモデルの検証

    佐藤 晃平, 小野 喜章, 河合 穂高, 中野 敬介, 長塚 仁, 佐々木 朗

    第63回歯科基礎医学会学術大会  2021年10月9日 

     詳細を見る

    開催年月日: 2021年10月9日 - 2021年10月11日

    会議種別:ポスター発表  

    researchmap

  • 侵襲性歯周炎の血液診断マーカー候補となる細胞外小胞由来マイクロRNAとその炎症誘導機構

    森彩乃, 山本直史, 河村麻理, 河本美奈, 伊東昌洋, 小野喜章, 中山真彰, 山城圭介, 大森一弘, 高柴正悟

    第42回日本炎症・再生医学会  2021年7月7日 

     詳細を見る

    開催年月日: 2021年7月7日 - 2021年7月8日

    会議種別:ポスター発表  

    researchmap

  • 口腔扁平上皮癌の癌性骨痛におけるHMGB1の役割に関する検討

    中村友哉, 奥井達雄, 坂本裕美, 竜門省二, 長谷川利聡, 國定勇希, 小野喜章, 伊原木聰一郎, 佐々木朗

    第65回日本口腔外科学会総会・学術大会 

     詳細を見る

    開催年月日: 2020年11月

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 包括的治療により整容性と咬合の改善を図った多骨性線維性骨異形成症の1例

    中村裕子, 吉岡德枝, 國定勇希, 小野喜章, 中村友哉, 伊原木聰一郎, 佐々木朗

    第65回日本口腔外科学会総会・学術大会 

     詳細を見る

    開催年月日: 2020年11月

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 頸部郭清術後に後頭リンパ節への後発転移を認めた舌癌の一例

    小野喜章, 吉岡德枝, 増井正典, 小畑協一, 國定勇希, 奥井達雄, 伊原木聰一郎, 河合穂高, 長塚仁, 佐々木朗

    第65回日本口腔外科学会総会・学術大会 

     詳細を見る

    開催年月日: 2020年11月

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 銅キレート剤はCDDPの細胞外排出抑制を介してCDDPの抗腫瘍効果を増強する

    竜門省二, 奥井達雄, 國定勇希, 志茂剛, 岸本晃治, 長谷川利聡, 小野喜章, 増井正典, 伊原木聰一郎, 佐々木朗

    第65回日本口腔外科学会総会・学術大会 

     詳細を見る

    開催年月日: 2020年11月

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 顎骨壊死を伴ったEBV陽性皮膚粘膜潰瘍(EBV-MCU)の2例

    竜門省二, 岸本晃治, 奥井達雄, 吉岡德枝, 小畑協一, 國定勇希, 増井正典, 小野喜章, 伊原木聰一郎, 佐々木朗

    第30回日本口腔内科学会・第33回日本口腔診断学会 合同学術大会 

     詳細を見る

    開催年月日: 2020年10月

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 口腔扁平上皮癌細胞由来エクソソームを介したシスプラチン耐性獲得機構の解明

    小野喜章, 奥井達雄, 國定勇希, 小畑協一, 吉岡徳枝, 中村友哉, 伊原木聰一郎, 佐々木朗

    第38回 日本口腔腫瘍学会総会・学術大会 

     詳細を見る

    開催年月日: 2020年1月23日 - 2020年1月24日

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 分子シャペロントリオによるエクソソーム制御,腫瘍悪性化およびマクロファージ分極について

    江口傑徳, 小野喜章, 河合穂高, チャン・チエン・マン, 十川千春, 奥舎有加, 岡元邦彰

    第14回 臨床ストレス応答学会 

     詳細を見る

    開催年月日: 2019年11月2日 - 2019年11月3日

    会議種別:口頭発表(一般)  

    researchmap

  • 口腔扁平上皮癌診断・治療における分子シャペロンHSP90含有エクソソームの可能性

    小野喜章, 江口傑徳, 中野敬介, 河合穂高, 佐々木朗

    第64回日本口腔外科学会総会・学術大会 

     詳細を見る

    開催年月日: 2019年10月25日 - 2019年10月27日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • ケルビズムと診断された上下顎骨中心性巨細胞肉芽腫の1例

    小畑協一, 岸本晃治, 西山明慶, 柴田茜, 小野喜章, 野島鉄人, 佐々木 朗

    第64回日本口腔外科学会総会・学術大会 

     詳細を見る

    開催年月日: 2019年10月25日 - 2019年10月27日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 口腔癌エクソソームによる腫瘍悪性化及びマクロファージM2分極における分子シャペロントリオの重要性

    江口傑徳, 小野喜章, 河合穂高, チャン・チエン・マン, 十川千春, 奥舎有加, 岡元邦彰

    第6回日本細胞外小胞学会JSEV 

     詳細を見る

    開催年月日: 2019年10月24日 - 2019年10月25日

    会議種別:口頭発表(一般)  

    researchmap

  • 下顎枝から翼突下顎隙に大きく膨隆した含歯性嚢胞の一例

    西山明慶, 伊原木聰一郞, 奥井達雄, 小野喜章, 佐々木朗

    第67回日本口腔科学会中国・四国地方部会  2019年10月12日 

     詳細を見る

    開催年月日: 2019年10月12日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • ニコチンが口腔癌細胞に与える影響の検討

    伊原木聰一郞, 清水理恵子, 奥井達雄, 高畠清文, 河合穂高, 小野喜章, 長塚仁, 佐々木朗

    第67回日本口腔科学会中国・四国地方部会  2019年10月12日 

     詳細を見る

    開催年月日: 2019年10月12日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 脂質・コレステロール排出ポンプABCG1標的による腫瘍内エクソソーム蓄積および腫瘍縮小

    江口傑徳, 十川千春, 難波友里, 奥舎有加, 河合穂高, 小野喜章, 板垣まみ, 村上純, 大山和美, 浅海淳一, 岡元邦彰

    第92回日本薬理学会年会 

     詳細を見る

    開催年月日: 2019年3月14日 - 2019年3月16日

    researchmap

  • MMP9プロモーター活性を指標とした三次元培養システムを用いた抗がん剤スクリーニングによる薬剤再開発

    十川千春, 江口傑徳, 奥舎有加, 大山和美, 小野喜章, 十川紀夫, 岡元邦彰

    第92回日本薬理学会年会 

     詳細を見る

    開催年月日: 2019年3月14日 - 2019年3月16日

    記述言語:日本語  

    researchmap

  • ニコチンは口腔扁平上皮癌のリンパ節転移とセツキシマブ耐性を促進する

    伊原木聰一郎, 清水理恵子, 小野喜章, 長塚仁, 佐々木朗

    第37回日本口腔腫瘍学会総会 

     詳細を見る

    開催年月日: 2019年1月24日 - 2019年1月25日

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 生検によって自然治癒した小児の下顎に生じたLangerhans細胞組織球症の1例

    小野喜章, 佐々木朗

    第31回日本小児口腔外科学会総会・学術大会  2019年 

     詳細を見る

    開催年月日: 2019年

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • Secretion of Extracellular Vesicles with Heat Shock Proteins by Three-dimensional Aggregative, Tumoroids of Resistant Adenocarcinomas and Metastatic Oral Cancer.

    Takanori Eguchi, Kisho Ono, Chiharu Sogawa, Yuri Namba, Yuka Okusha, Kuniaki Okamoto, Ken-ichi Kozaki, Stuart K Calderwood

    Biology of Extracellular Vesicles 2018 

     詳細を見る

    開催年月日: 2018年12月12日 - 2018年12月16日

    記述言語:英語   会議種別:ポスター発表  

    researchmap

  • Tumoroid Never Knows? 腫瘍オルガノイドと細胞外小胞からみる難治性がん研究・治療のミライ

    江口傑徳, 小野喜章, 奥舎有加, 藤原敏史, 十川千春, Stuart Calderwood

    第41回 日本分子生物学会年会 

     詳細を見る

    開催年月日: 2018年11月28日 - 2018年11月30日

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 口腔扁平上皮癌細胞由来EVの網羅的プロテオーム解析による腫瘍進展・転移因子の探索

    小野喜章, 江口傑徳, 佐々木朗

    第63回日本口腔外科学会総会・学術大会  2018年11月2日 

     詳細を見る

    開催年月日: 2018年11月2日 - 2018年11月4日

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • ニコチンは口腔扁平上皮癌細胞のセツキシマブ耐性を促進する

    清水理恵子, 伊原木聰一郎, 江口傑徳, 奥井達雄, 高畑清文, 河合穂高, 小野喜章, 岡元邦彰, 長塚仁, 佐々木朗

    第40回岡山歯学会総会・学術集会  2018年10月21日 

     詳細を見る

    開催年月日: 2018年10月21日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 細胞外小胞のHSPに富む特性は、転移性口腔癌細胞の生存を担う

    小野喜章, 江口傑徳, 十川千春, 佐々木朗

    第77回日本癌学会学術総会 

     詳細を見る

    開催年月日: 2018年9月27日 - 2018年9月29日

    記述言語:英語   会議種別:口頭発表(一般)  

    researchmap

  • 口腔扁平上皮癌診断・治療における分子シャペロンHSP90含有細胞外小胞の可能性

    小野喜章, 江口傑徳, 十川千春, 奥舎有加, 河合穂高, 中野敬介, 佐々木朗, 岡元邦彰, 小崎健一

    第60回歯科基礎医学会学術大会  2018年9月5日 

     詳細を見る

    開催年月日: 2018年9月5日 - 2018年9月7日

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 知覚神経の興奮は骨内での乳がん進展に寄与する

    奥井達雄, 小野喜章, 佐々木朗

    第60回歯科基礎医学会学術大会 

     詳細を見る

    開催年月日: 2018年9月5日 - 2018年9月7日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 癌の治療抵抗性と転移におけるHSP90およびMMP3の役割

    江口傑徳, 小野喜章, 奥舎有加, 十川千春, 内部健太, 中野敬介, 奥井達雄, 滝川正春, 岡元邦彰, スチュアート・カルダーウッド

    第60回歯科基礎医学会学術大会 

     詳細を見る

    開催年月日: 2018年9月5日 - 2018年9月7日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 核内およびエクソソーム中に存在するMMPs/PEXの癌進展における役割とその抑制

    奥舎有加, 江口傑徳, 十川千春, 小野喜章, 奥井達雄, 中野敬介, 岡元邦彰

    第60回歯科基礎医学会学術大会 

     詳細を見る

    開催年月日: 2018年9月5日 - 2018年9月7日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 急速転移性癌細胞株由来細胞外小胞による破骨細胞分化および癌細胞浸潤の制御

    板垣まみ, 十川千春, 奥舎有加, 江口傑徳, 小野喜章, 岡元邦彰

    第60回歯科基礎医学会学術大会 

     詳細を見る

    開催年月日: 2018年9月5日 - 2018年9月7日

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 抗体医薬耐性および上皮間葉転換におけるがん細胞外小胞の役割

    江口傑徳, 小野喜章, 藤原敏史, 十川千春, スチュアート・カルダーウッド

    第5回日本細胞外小胞学会JSEV 

     詳細を見る

    開催年月日: 2018年8月29日 - 2018年8月31日

    記述言語:英語   会議種別:口頭発表(一般)  

    researchmap

  • 口腔扁平上皮癌細胞株が分泌するエクソソーム中に見つかった腫瘍進展・転移因子

    小野喜章, 江口傑徳, 佐々木朗

    第36回 日本口腔腫瘍学会総会・学術大会  2018年1月25日 

     詳細を見る

    開催年月日: 2018年1月25日

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 口腔扁平上皮癌細胞由来エクソソームに含まれるプロテオームの特性

    小野喜章, 江口傑徳, 十川千春, 村上純, 藤原敏史, 笠井智成, 妹尾昌治, 佐々木朗, 小崎健一, 岡元邦彰

    第40回 日本分子生物学会年会.  2017年12月6日 

     詳細を見る

    開催年月日: 2017年12月6日 - 2017年12月9日

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 口腔扁平上皮癌細胞株が分泌するエクソソームについての検討

    小野喜章, 江口傑徳, 十川千春, 村上純, 藤原敏史, 笠井智成, 妹尾昌治, 岡元邦彰, 佐々木朗, 小崎健一

    第16回 中国四国口腔癌研究会  2017年11月10日 

     詳細を見る

    開催年月日: 2017年11月10日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 口腔扁平上皮癌細胞由来エクソソームに含まれる分子シャペロンについての検討

    小野喜章, 江口傑徳, 十川千春, 村上純, 藤原敏史, 笠井智成, 妹尾昌治, 佐々木朗, 小崎健一, 岡元邦彰

    第12回 臨床ストレス応答学会  2017年11月4日 

     詳細を見る

    開催年月日: 2017年11月4日 - 2017年11月5日

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • EGFR標的抗体薬セツキシマブによる口腔癌由来エクソソームの制御

    藤原敏史, 江口傑徳, 十川千春, 小野喜章, 村上純, 浅海淳一, 小崎健一, 岡元邦彰

    第38回 岡山歯学会総会・学術大会  2017年10月1日 

     詳細を見る

    開催年月日: 2017年10月1日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 舌癌細胞株由来エクソソーム解析による頚部リンパ節転移マーカーの探索

    第76回 日本癌学会学術総会 

     詳細を見る

    開催年月日: 2017年9月28日 - 2017年9月30日

    記述言語:英語   会議種別:口頭発表(一般)  

    researchmap

  • 転移能の異なる2種類の舌癌細胞株由来エクソソームについて比較検討 第4回日本細胞外小胞学会

    小野喜章, 江口傑徳, 十川千春, 村上純, 藤原敏史, 笠井智成, 妹尾昌治, 佐々木朗, 小崎健一, 岡元邦彰

    第4回日本細胞外小胞学会JSEV 

     詳細を見る

    開催年月日: 2017年8月30日 - 2017年9月1日

    記述言語:英語   会議種別:ポスター発表  

    researchmap

  • 腫瘍微小環境下での上皮間葉転換およびエクソソーム変化の解析

    藤原敏史, 十川千春, 小野喜章, 村上純, 浅海淳一, 小崎健一, 江口傑徳

    第40回 日本分子生物学会年会 

     詳細を見る

    開催年月日: 2016年11月30日 - 2016年12月2日

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 口腔扁平上皮癌細胞株および口腔上皮細胞株が放出するエクソソームの解析

    藤原敏史, 十川千春, 小野喜章, 村上純, 小崎健一, 江口傑徳

    第37回 岡山歯学会総会・学術大会  2016年10月16日 

     詳細を見る

    開催年月日: 2016年10月16日

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 悪性黒色腫に対する新規血管新生阻害薬terreinの抗腫瘍効果の検討

    伊原木聰一郎, 小野喜章, 小畑協一, 増井正典, 吉岡德枝, 佐々木朗

    第45回日本頭頸部癌学会  2021年6月 

     詳細を見る

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 関節頭付き再建プレートとチタンメッシュトレーを併用した腸骨海綿骨移植により下顎再建を行った症例

    吉岡德枝, 伊原木聰一郎, 小野喜章, 小畑協一, 佐々木朗

    第45回日本頭頸部癌学会  2021年6月 

     詳細を見る

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 口腔領域に発生したEBV-positive mucocutaneous ulcerに関する統計学的検討

    小畑協一, 伊原木聰一郎, 小野喜章, 増井正典, 矢尾真弓, 岸本晃治, 吉岡德枝, 佐々木朗

    第45回日本頭頸部癌学会  2021年6月 

     詳細を見る

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • 根治的頸部郭清術後に後頭リンパ節転移をきたした舌癌の一例

    小野喜章, 吉岡徳枝, 小畑協一, 増井正典, 岸本晃治, 伊原木聰一郎, 塚仁, 佐々木朗

    第45回日本頭頸部癌学会  2021年6月 

     詳細を見る

    記述言語:日本語   会議種別:ポスター発表  

    researchmap

  • Duplication of external jugular vein

    小野喜章

    第1回 口腔顎顔面外科解剖リサーチカンファレンス  2021年5月8日 

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

  • 口腔扁平上皮癌における術前化学療法に伴う腫瘍浸潤リンパ球の変化

    高倉裕明, 銅前昇平, 吉田祥子, 國定勇希, 小野喜章, 岸本晃治, 佐々木 朗

    第40回 日本頭頸部癌学会  2016年6月1日 

     詳細を見る

    記述言語:日本語   会議種別:口頭発表(一般)  

    researchmap

▼全件表示

受賞

  • 優秀ポスター賞

    2023年5月   第77回日本口腔科学会学術集会   口腔癌の細胞外小胞と銅輸送経路に着目したシスプラチン耐性機構の解明と克服のための挑戦的研究

    小野喜章、竜門省二、小畑協一、河合穂高、奥井達雄、伊原木聰一郎

     詳細を見る

  • 優秀ポスター賞

    2023年2月   第41回日本口腔腫瘍学会総会・学術大会   頭頸部癌におけるセツキシマブ感受性予測バイオマーカーとしてのEpCAMの可能性

    小野喜章、梅森洸樹、中村友哉、小川辰雄、金本栄華、吉田国弘、小畑協一、竜門省二、柚鳥宏和、河合穂高、片瀬直樹、奥井達雄、長塚仁、伊原木聰一郎

     詳細を見る

  • 奨励論文賞

    2022年12月   第43回 岡山歯学会学術集会  

    小野喜章

     詳細を見る

  • 学術研究費助成事業 川崎医学・医療福祉学振興会

    2021年  

    小野喜章

     詳細を見る

  • 生物学研究奨励賞 両備檉園記念財団研究助成

    2021年  

    小野喜章

     詳細を見る

  • 研究活動助成事業 ウエスコ学術振興財団

    2021年  

    小野喜章

     詳細を見る

  • 優秀ポスター賞

    2018年11月   第63回日本口腔外科学会総会・学術大会   口腔扁平上皮癌細胞由来EVの網羅的プロテオーム解析による腫瘍進展・転移因子の探索

    小野喜章, 江口傑徳, 佐々木朗

     詳細を見る

  • モリタ優秀発表賞

    2018年9月   第60回歯科基礎医学会学術大会   口腔扁平上皮癌診断・治療における分子シャペロンHSP90含有細胞外小胞の可能性

    小野喜章, 江口傑徳, 十川千春, 奥舎有加, 河合穂高, 中野敬介, 佐々木朗, 岡元邦彰, 小崎健一

     詳細を見る

  • 若手研究奨励賞

    2017年11月   第12回 臨床ストレス応答学会   口腔扁平上皮癌細胞由来エクソソームに含まれる分子シャペロンについての検討

    小野喜章, 江口傑徳, 十川千春, 村上純, 藤原敏史, 笠井智成, 妹尾昌治, 佐々木朗, 小崎健一, 岡元邦彰

     詳細を見る

▼全件表示

共同研究・競争的資金等の研究

  • 腫瘍免疫微小環境ネットワーク内のがん関連線維芽細胞と細胞外小胞を標的とした新規治療戦略の開発

    2025年11月 - 2026年10月

    公益財団法人金原一郎医学医療振興財団  第40回基礎医学医療研究助成金 

    小野喜章

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • 口腔癌オルガノイドと細胞外小胞による新規診断法開発

    2025年04月 - 2026年03月

    公益財団法人 上原記念生命科学財団  海外留学助成 

    小野喜章

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • 口腔がんの細胞外小胞を用いた新規分子標的治療効果判定システムの開発

    2025年04月 - 2026年03月

    公益財団法人 西山デンタルアカデミー  NDA歯科医療研究助成制度 

    小野喜章

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • 口腔癌の細胞外小胞を介したシスプラチン耐性獲得機構の解明

    2021年10月 - 2022年10月

    両備檉園記念財団研究助成 

    小野喜章

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • 口腔癌の細胞外小胞を介したシスプラチン耐性獲得機構の解明

    2021年10月 - 2022年10月

    公益財団法人ウエスコ学術振興財団研究  研究活動費助成事業 

    小野喜章

      詳細を見る

    担当区分:研究代表者 

    researchmap

  • 口腔癌の細胞外小胞を介したシスプラチン耐性獲得機構の解明

    研究課題/領域番号:21K17115  2021年04月 - 2024年03月

    日本学術振興会  科学研究費助成事業 若手研究  若手研究

    小野 喜章

      詳細を見る

    配分額:4550000円 ( 直接経費:3500000円 、 間接経費:1050000円 )

    口腔癌の進行例や再発例の多くはシスプラチン (CDDP) を用いた化学療法に耐性を示し, 予後は不良である. CDDPの耐性を獲得するメカニズムに関して様々な報告があるものの, 実際の治療においてCDDPに対する耐性の多くは多因子性と考えられている. そのため有害事象の軽減や個別化治療などの観点から, 新たなメカニズムの解明や新規治療標的の探究が求められている. 近年, エクソソームをはじめとする細胞外小胞 (EV) が多くのがん種における治療抵抗性の主要な調節因子として注目されている. 抗癌剤の細胞外への排出や, 細胞性質変化の誘導に働くことが報告されているが, 口腔癌のCDDP耐性獲得機構にEVが関与していることを示した報告は少ない. また, 口腔癌細胞の分泌するEVが, どのようにCDDP耐性獲得に働くのか, という課題が存在している. 申請者の予備的実験から, CDDP耐性口腔癌細胞から精製したEVをCDDP感受性口腔癌細胞に添加することでこのレシピエントの細胞がCDDP耐性能を獲得したこと, そして口腔癌細胞にEV分泌阻害剤を作用させることで,CDDPに対する感受性が増強されたことから口腔癌におけるEVのCDDP耐性への影響は十分考えられうるものである. 本研究では口腔癌から採取したEVを用い, 口腔癌の薬剤耐性メカニズムにおけるEVの果たす役割について明らかにする. さらに, EV中における薬剤耐性関連分子を明らかにし, 薬剤耐性を克服する新たな治療法の探索を行う.
    初年度である令和3年度では, In vitroにおいて口腔癌細胞株のCDDP耐性亜株の樹立, EVの精製および機能評価, ターゲット分子の同定さらにEVとの関連性評価に至るまで研究を進めることができた. 進捗状況蘭にその詳細を示した。

    researchmap

  • 癌の骨破壊病変に対する銅のキレートを応用した治療戦略の構築とその制御機構の解析

    研究課題/領域番号:20H03889  2020年04月 - 2023年03月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    佐々木 朗, 志茂 剛, 奥井 達雄, 吉岡 徳枝, 伊原木 聰一郎, 増井 正典, 小野 喜章

      詳細を見る

    配分額:13260000円 ( 直接経費:10200000円 、 間接経費:3060000円 )

    本研究課題は,生体銅を標的とした癌の骨破壊病変に対する新規治療法の開発とその制御機構の解析を目的としている。具体的には,銅のキレート薬(Ammonium Tetrathiomolybdate;TM)の癌の骨破壊病変(骨浸潤・高カルシウム血症・骨転移・癌性骨疼痛)について,臨床材料ならびに疾患モデルを作製してその有効性と作用機序を解析する。本年度は,口腔癌の顎骨浸潤した手術材料を用いて,主としてLOXを中心とした骨吸収の作業仮説を病理学的評価するために細胞外銅流出トランスポーター(ATP7B),破骨細胞誘導因子RANKL,銅依存性アミンオキシダーゼであるLysyl oxidase (LOX)発現に関して免疫組織学的検索を行った。初期進展癌,中程度進展癌,進行癌(虫喰い構造)である。いずれも蛋白発現は陽性で,組織アレイ検索でも同様の結果であった。骨破壊の程度(腫瘍進行度)に伴い蛋白発現が増加する傾向があり,腫瘍の骨破壊と銅関連因子の発現は相関する可能性が示唆された。症例数の追加ならびに他の骨吸収関連因子(OPGなど)について検討中である。次に,動物実験モデルに対する銅キレート剤TMの効果の検証であるが,口腔扁平上皮癌細胞株TM10(理研細胞バンク)を移植した高カルシウム血症動物モデルを用いてTMの薬物効果を検証中である。既に癌細胞移植モデルの作製は終了しており,高カルシウム血症発現前からのTMの予防的効果と症状発現後の治療的効果について検証中である。また癌性骨疼痛に関してはHigh-mobility group box 1の関与について結果を示しており,TMの効果の指標として検討予定である。

    researchmap

  • 口腔癌エクソソームの網羅的解析による新規体液診断・治療体系の確立

    研究課題/領域番号:19K24072  2019年08月 - 2021年03月

    日本学術振興会  科学研究費助成事業 研究活動スタート支援  研究活動スタート支援

    小野 喜章

      詳細を見る

    配分額:2860000円 ( 直接経費:2200000円 、 間接経費:660000円 )

    エクソソームはより簡便で低侵襲なリキッドバイオプシーのリソースに用いるバイオマーカーとして注目されている. 一般的に口腔扁平上皮癌(OSCC)では, 血中SCCが腫瘍マーカーとして用いられているが, その感度は決して高くない. より有用な腫瘍マーカーの開発が期待されている.
    本研究では, 転移性の異なるOSCC細胞株から精製したエクソソームの網羅的発現解析と細胞実験により, 腫瘍進展/転移に関わるマーカーとなりうるタンパク質の同定を目指している. さらに, 同定したエクソソームマーカー分子の生物学的機能を評価し, OSCC進展における悪性形質獲得までの分子機構の一端を解明する. また, 臨床的有用性の検討を行うために, OSCC患者の臨床検体サンプルからエクソソームを精製することを試み, 健常者との差異を見出すことで, 画期的なバイオマーカーの開発に貢献することを目指す.
    これまでの研究において, 2種類の転移性の異なるOSCC細胞株から精製したエクソソームのプロテオーム解析を行い, 高転移性OSCC細胞由来のエクソソームで発現が増加しているタンパク質群として分子シャペロンタンパク質を見出した. 中でも, HSP90α/βがより高転移性OSCC細胞由来エクソソームにおいて有意に高検出であった. 前年度は, そのエクソソーム内HSP90がOSCC進展に影響する可能性をより強固なものとするため, RNAi法を応用することで, HSP90欠失エクソソームの精製技術を確立した. 更に, エクソソーム内HSP90の機能評価のため, 培養細胞を用いたエクソソーム取り込み実験により, エクソソーム内のHSP90が様々な悪性形質獲得の分子機構(上皮間葉転換の促進, マクロファージのM2分極など)に関わっていることが示唆された.

    researchmap

  • 新規体液診断・治療体系の開発に向けた口腔がんエクソソームの解析

    公益財団法人川崎医学・医療福祉学振興会 

    小野喜章

      詳細を見る

    担当区分:研究代表者 

    researchmap

▼全件表示